救急外来　オススメ処方・ダメ処方

出版社： 中外医学社
著者：
発行日： 2023-05-20
分野： 臨床医学：一般  >  救命/救急
ISBN： 9784498166523
電子書籍版： 2023-05-20 （1版1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

5,280 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

5,280 円(税込)

購入する

商品紹介

各診療科スペシャリストたちによる，現場ですぐに使えるオススメ処方・ダメ処方．“各診療科のあたりまえを全科のあたりまえに”をテーマに，役に立つTips ＆ Pitfallsについて薬剤の処方を中心に簡潔にまとめました．救急・循環器・呼吸器・消化器・感染症・小児科・産婦人科など，20テーマに及ぶ内容を網羅しており，フレッシュな先生にも，ベテランの先生にも有用な，まさにすべての臨床医にご一読いただきたい渾身の一冊です！

目次

  • CHAPTER 1　救急
    【オススメ処方】
    　●1　ブドウ糖を投与する患者ではビタミンB1の投与も忘れずに！
    　●2　PSVT患者，血行動態が安定しているのならば，まずは修正バルサルバ！
    　●3　痙攣患者に盲目的にジアゼパムではなく，まずはバイタルサインの確認を！
    　ほか
    【ダメ処方】
    　●1　アナフィラキシーに対してまずは抗ヒスタミン薬，ステロイドはダメ！
    　●2　めまい患者に対するルーチンの頭部CTはダメ！
    　●3　軽症頭部外傷患者に対するルーチンの頭部CTはダメ！
    　ほか

    CHAPTER 2　救急（中毒）
    【オススメ処方】
    　●1　対症療法の効果が乏しい局所麻酔薬中毒に脂肪乳剤を投与する
    　●2　メタノール中毒にホメピゾールを用いる
    【ダメ処方】
    　●1　急性アルコール中毒患者に排泄目的に点滴を行うのはダメ！
    　●2　薬物中毒患者さんにいつも吐根シロップを飲ませるのはダメ！
    　●3　気道確保なしに胃洗浄を行うのはダメ！
    　ほか

    CHAPTER 3　緩和救急系
    【オススメ処方】
    　●1　癌性疼痛に対してオピオイド導入はためらわない！
    　●2　呼吸困難　モルヒネを少量から使ってみる
    　●3　癌性腹水　腹水穿刺を施行する
    【ダメ処方】
    　●1　DNAR患者をすぐ看取り方針にするのはダメ！
    　●2　終末期の患者に大量の輸液をするのはダメ！

    CHAPTER 4　プライマリ・ケア救急
    【オススメ処方】
    　●1　海の生物に刺された時の痛みに対し「45℃温水に20分つける」を処方する
    　●2　高齢入院患者に高齢者総合機能評価を処方する　
    　●3　自分自身の薬理作用を意識し，医師である自分を処方する
    　ほか
    【ダメ処方】
    　●1　浮腫の患者に，「薬剤性浮腫を否定」せずに利尿薬を処方するのはダメ！
    　●2　高齢男性の風邪患者にPL配合顆粒の処方は要注意！
    　●3　DOACおよびワーファリン内服中の患者への抗菌薬処方は要注意！
    　ほか

    CHAPTER 5　循環器系
    【ダメ処方】
    　●1　低心機能の頻脈性心房細動にベラパミル静注は危ない
    　●2　頻脈性心房細動にとりあえずピルジカイニドはダメ！
    　　　　　腎機能障害患者へのピルジカイニドには注意
    　●3　水分過剰がない心不全に盲目的にフロセミドはダメ！
    　ほか

    CHAPTER 6　呼吸器系
    【オススメ処方】
    　●1　循環器系適応のあるCOPD患者へのβ遮断薬
    　●2　吸入薬を処方する場合はスペーサーの案内ができるように
    　●3　肺真菌症の治療にはジェネリックがオススメ
    【ダメ処方】
    　●1　テオフィリン内服患者への安易なアミノフィリン点滴はダメ！
    　●2　アスピリン喘息（NSAIDs過敏喘息：N-ERD）に対するビソルボン®吸入液の処方はダメ！
    　●3　音楽関係の仕事に従事する患者へのフラベリック®はダメ！
    　ほか

    CHAPTER 7　感染症系
    【オススメ処方】
    　●1　発熱性好中球減少症患者に対して，早急に血液培養を採取し，
    　　　　抗緑膿菌活性のある抗菌薬を投与する　
    　●2　急性膀胱炎に対してルーチンのキノロン系の処方ではなく，
    　　　　　ST合剤もしくはβラクタム系を処方する
    　●3　A群溶連菌による壊死性軟部組織感染症を疑う場合は，
    　　　　早急にデブリードマン，クリンダマイシンを併用する
    　ほか
    【ダメ処方】
    　●1　カバーする微生物の想定なしにカルバペネム系抗菌薬を使用するのはダメ！
    　●2　オーグメンチン配合錠のみを処方するのはダメ！
    　●3　経口第3世代セフェム系抗菌薬を処方するのはダメ！
    　ほか

    CHAPTER 8　産婦人科系
    【オススメ処方】
    　●1　妊婦の細菌尿にペニシリン系またはセフェム系抗菌薬を処方する
    　●2　妊婦と産後女性に新型コロナウイルス／インフルエンザの予防接種を推奨する
    　●3　妊娠後期の女性に百日咳の予防接種を提案する
    　ほか
    【ダメ処方】
    　●1　妊婦の風邪症状にレボフロキサシン（クラビット®）を処方するのはダメ！
    　●2　妊婦の腰痛に湿布（非ステロイド性消炎鎮痛剤）を処方するのはダメ！
    　●3　妊婦の足の浮腫にフロセミド（ラシックス®）を処方するのはダメ！
    　ほか

    CHAPTER 9　小児科系
    【オススメ処方】
    　●1　小児の疼痛管理の王様　アセトアミノフェン
    　●2　小児でも結構使える！　イブプロフェン
    　●3　疼痛管理の大御所，モルヒネ
    　ほか
    【ダメ処方】
    　●1　ピボキシル基含有の抗菌薬は低血糖を引き起こ
    　●2　短絡的な制吐薬処方よりも大事な「ホームケアの指導」
    　●3　整腸剤を正しく処方しよう！

    CHAPTER 10　整形外科系〈藤井達也〉
    　●1　NSAIDs処方時は既往歴の確認と潰瘍予防のためのPPI処方を
    　●2　アセトアミノフェンの量はリスクを考慮し高用量で
    　●3　骨折，捻挫では痛み止めの前に固定を！
    　ほか
    【ダメ処方】
    　●1　痛みのある患者に救急外来で弱オピオイドやプレガバリン，
    　　　　ミロガバリンを出すのはダメ！
    　●2　骨折患者が入院したのに頓用鎮痛薬のみではダメ！

    CHAPTER 11　脳神経系
    【オススメ処方】
    　●1　片頭痛にトリプタンの正しい内服タイミングの「説明」処方がオススメ！
    　●2　ドパミンアゴニストの置換はドパミンアゴニストで行うのがオススメ！
    　●3　脳梗塞やTIAが否定しきれない場合に，アスピリンを処方しておくこと！
    　ほか
    【ダメ処方】
    　●1　Parkinson病治療薬をいきなり中止するのはNG！
    　●2　認知症が疑われる人に不用意に抗コリン作用のある薬を使用するのはNG！
    　●3　認知症に対して漫然と抗認知症薬を継続するのはNG！
    　ほか

    CHAPTER 12　精神科系
    【オススメ処方】
    　●1　アルコール使用障害が疑われる入院患者に，ベンゾジアゼピン受容体作動薬を処方する
    【ダメ処方】
    　●1　せん妄の原因検索を行わずに鎮静を目的とした処方はダメ処方である　
    　●2　救急外来で抗うつ薬を処方するのはダメ！
    　●3　救急外来で不眠にベンゾジアゼピン受容体作動薬を処方するときは注意！
    　ほか

    CHAPTER 13　皮膚科系
    【オススメ処方】
    　●1　外用薬は混合しない
    　●2　妊婦の痒みに対しては非鎮静性の抗ヒスタミン薬投与を
    【ダメ処方】
    　●1　とりあえずステロイド抗菌薬配合薬処方はダメ！
    　●2　漫然と皮膚科のDo処方を継続するのはダメ！
    　●3　白癬が「怪しい」例での抗真菌薬はダメ！
    　●4　分子標的薬使用患者に生じた皮疹に対して安易に薬剤中止にしない

    CHAPTER 14　腎臓系
    【オススメ処方】
    　●1　腎機能障害患者であっても抗菌薬初回投与はfull dose！
    　●2　薬剤を処方する時にはeGFRではなく，個別eGFRもしくはCCrを計算しよう！
    【ダメ処方】
    　●1　透析患者への無条件での生理食塩水の点滴をやめる！
    　●2　入院予定の患者に目的のない低張液の維持輸液を行うことを止めよう！
    　●3　高齢者への解熱鎮痛薬にNSAIDsの処方はやめる！
    　ほか

    CHAPTER 15　膠原病系
    【オススメ処方】
    　●1　朝内服していなかったステロイド内服補充
    　●2　免疫抑制薬内服中の帯状疱疹にアシクロビル点滴相談
    　●3　痛風・偽痛風患者へのNSAIDs（アセトアミノフェンじゃなくNSAIDs）＋アイシング
    　ほか
    【ダメ処方】
    　●1　メトトレキサートのDo処方はやめよう
    　●2　いきなりロイコボリン®レスキュー！　には注意！その前に主治医（専門医）に相談を！
    　●3　アザルフィジンはサルファ系なので注意！
    　●4　UTIだからバクタ！　もちょっと待って

    CHAPTER 16　消化器系
    【オススメ処方】
    　●1　腹部画像診断で異常がない腹痛ではカーネット徴候をみる！
    　●2　腹痛に蕁麻疹や呼吸困難を伴ったらアニサキス・アナフィラキシーを疑い
    　　　　魚介類の喫食聴取とアドレナリン！
    　●3　憩室炎患者は発症1.5カ月をめどに大腸内視鏡検査を勧める！
    　●4　救急室での機能性ディスペプシア診断にご用心！
    　　　　若い女性の食後に悪化する腹痛はCACSを疑いドプラエコー！
    【ダメ処方】
    　●1　肝障害に盲目的なウルソの処方はダメ！鑑別診断こそが肝（キモ）だ！
    　●2　急性膵炎患者にルーチンで蛋白分解酵素阻害薬や抗菌薬を投与する
    　●3　静脈瘤性上部消化管出血ではPPIのみを投与して安心するな！
    　ほか

    CHAPTER 17　内分泌系
    【オススメ処方】
    　●1　バセドウ病患者の発熱では無顆粒球症を考慮し白血球数分画を確認する
    　●2　癌患者では高カルシウム血症を意識する
    【ダメ処方】
    　●1　高血糖症で劇症型1型糖尿病を想起しない！
    　●2　1型糖尿病患者が悪心・嘔吐・腹痛でERを受診，血糖値が高くないため，
    　　　　DKAを否定し，急性胃腸炎として，胃腸薬を処方して帰宅させるのは危険！
    　●3　ERでDKA（糖尿病性ケトアシドーシス）と診断して，
    　　　　まずは速効型インスリンを5単位ワンショット静注するのはダメ！

    CHAPTER 18　血液内科系
    【オススメ処方】
    　●1　Transferrin saturation（血清鉄／TIBC）20％未満への鉄剤投与
    　●2　難治性鉄欠乏性貧血でピロリ菌が陽性の際の除菌療法
    　●3　新規処方薬開始5〜10日後の血小板減少はDITPを疑い，被疑薬中止
    　●4　血液疾患で腎機能障害を見たら画像検査を検討する
    　ほか
    【ダメ処方】
    　●1　血液疾患既往のある患者の発熱に対し，安易な抗菌薬・解熱剤処方はダメ！
    　●2　血液疾患の嘔気・嘔吐に採血なしで制吐薬の処方はダメ！

    CHAPTER 19　耳鼻科系
    【オススメ処方】
    　●1　Bell麻痺に対して抗ウイルス薬を投与する時はステロイド併用投与も忘れずに
    【ダメ処方】
    　●1　虫が耳に入った場合に，キシロカイン噴霧は要注意
    　●2　小児の中耳炎に安易な抗菌薬はダメ！
    　●3　鼻出血のガーゼ・タンポンに抗菌薬軟膏・内服は不要

    CHAPTER 20　マイナーエマージェンシー
    【オススメ処方】
    　●1　化学眼症には十分量の洗浄を行うのがオススメ！
    　●2　鼻血で受診した患者には，まずは正しい用手圧迫法の指導を行うのがオススメ！
    【ダメ処方】
    　●1　眼痛を訴える患者にベノキシール®を「処方」するのはNG！
    　●2　破傷風予防接種歴がない人の破傷風発症予防に破傷風トキソイドのみはNG！

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

CHAPTER 1 救急

P.1 掲載の参考文献
1) So YT. Wernicke encephalopathy. UpToDate. 2020.
 
P.2 掲載の参考文献
1) Appelboam A, et al. Posturalmodification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias(REVERT):a randomised controlled trial. Lancet. 2015;386:1747-53.
 
2) Pstras L, et al. In search of the optimal Valsalva maneuver position for the treatment of supraventricular tachycardia. Am J Emerg Med. 2016;34:2247.
PubMed
3) Gaudart P, et al. The reverse vagal manoeuvre:a new tool for treatment of supraven-tricular tachycardia? Am J Emerg Med. 2021;41:66-9.
 
P.5 掲載の参考文献
1) 日本アレルギー学会. アナフィラキシーガイドライン2022. 2022.
 
2) Hitti EA, et al. Acute allergic reactions in the emergency department:characteristics and management practices. Eur J Emerg Med. 2015;22:253-9.
PubMed
3) Campbell RL, et al. Emergency department diagnosis and treatment of anaphylaxis:a practice parameter. Ann Allergy Asthma Immunol. 2014;113:599-608.
PubMed
P.6 掲載の参考文献
1) Kounis NG. Kounis syndrome:an update on epidemiology, pathogenesis, diagnosis and therapeutic management. Clin Chem Lab Med. 2016;54:1545-59.
PubMed
2) Kounis NG, et al. Histamine-induced coronary artery spasm:the concept of allergic angina. Br J Clin Pract. 1991;45:121-8.
PubMed
3) Desai R, et al. Epidemiology of acute coronary syndrome co-existent with allergic/hypersensitivity/anaphylactic reactions(Kounis syndrome)in the United States:a nationwide inpatient analysis. Int J Cardiol. 2019;292:35-8.
PubMed
4) Kounis NG, et al. Kounis syndrome:a new twist on an old disease. Future Cardiol. 2011;7:805-24.
 
5) 十倉知久, 他. SARS-CoV-2ワクチン接種によるKounis症候群の1例. 日救急医会誌. 2021;32:603-5.
 
6) ファイザー株式会社. スルペラゾン(R)静注用添付文書. 2021年10月改訂(第1版). 2022年11月参照. https://www.info.pmda.go.jp/go/pack/6139500F1024_3_02/
 
P.7 掲載の参考文献
1) Durfey N, et al. Severe hyperkalemia:can the electrocardiogram risk stratify for short-term adverse events? West J Emerg Med. 2017;18:963-71.
PubMed
2) Idilbi N, et al. Hyperkalaemia mimics pseudostemi infarct pattern. BMJ Case Rep. 2022;15:e247444.
PubMed
P.8 掲載の参考文献
1) Choi JH, et al. Isolated vestibular syndrome in posterior circulation stroke:frequency and involved structures. Neurol Clin Pract. 2014;4:410-8.
PubMed
P.9 掲載の参考文献
1) Roffi M, et al. 2015 ESC Guidelines for the management of acute coronary syn-dromes in patients presenting without persistent ST-segment elevation:Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology(ESC). Eur Heart J. 2016;37:267-315.
 
2) Bang C, et al. Rapid rule-out of myocardial infarction after 30 minutes as an alterna-tive to 1 hour:The RACING-MI Cohort Study. Ann Emerg Med. 2022;79:102-12.
 
P.10 掲載の参考文献
1) Paal P, et al. Accidental hypothermia-an update:the content of this review is endorsed by the International Commission for Mountain Emergency Medicine(ICAR MEDCOM). Scand J Trauma Resusc Emerg Med. 2016;24:111.
PubMed
2) Rolf CM, et al. Hypothermic death in the arctic state. Acad Forensic Pathol. 2018;8:64-82.
PubMed
P.12 掲載の参考文献
1) Levy MM, et al. The Surviving Sepsis Campaign Bundle:2018 update. Intensive Care Med. 2018;44:925-8.
PubMed
2) 坂本 壮. 病棟急変ただいま対応中!その場の5分. 第4回敗血症ショック. J-COSMO. 2019:10;604-12.
 
3) Evans L, et al. Surviving sepsis campaign:international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181-247.
PubMed
4) De Backer D, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779-89.
 
5) De Backer D, et al. Dopamine versus norepinephrine in the treatment of septic shock:a meta-analysis. Crit Care Med. 2012;40:725-30.
PubMed
P.13 掲載の参考文献
1) Evans L, et al. Surviving sepsis campaign:international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181-247.
PubMed
2) Guerci P, et al. When to start vasopressin in septic shock:the strategy we propose. Crit Care. 2022;26:125.
PubMed
P.14 掲載の参考文献
1) Ranji SR, et al. Do opiates affect the clinical evaluation of patients with acute abdominal pain? JAMA. 2006;296:1764-74.
PubMed
2) 急性腹症診療ガイドライン出版委員会, 編. 急性腹症ガイドライン2015. 東京:医学書院;2015.
 
3) 坂本 壮. 腹痛と鎮痛薬. medicina. 56:2019:1620-3.
 
P.15 掲載の参考文献
1) Nakajima M, et al. Disaster-related carbon monoxide poisoning after the Great East Japan Earthquake, 2011:a nationwide observational study. Acute Med Surg. 2019;6:294-300.
PubMed
2) Weaver LK, et al. Carboxyhemoglobin half-life in carbon monoxide-poisoned patients treated with 100% oxygen at atmospheric pressure. Chest. 2000;117:801-8.
PubMed
3) Turgut K, et al. Comparison of non-invasive CPAP with mask use in carbon monox-ide poisoning. Am J Emerg Med. 2020;38:1454-7.
 
4) Ozturan IU, et al. Determination of carboxyhemoglobin half-life in patients with car-bon monoxide toxicity treated with high flow nasal cannula oxygen therapy. Clin Toxicol(Phila). 2019;57:617-23.
 
P.16 掲載の参考文献
1) Simonini A, et al. Advantages of ketamine in pediatric anesthesia. Open Med(Wars). 2022;17:1134-47.
PubMed
2) Shlobin NA, et al. Nonopioid postoperative pain management in neurosurgery. Neu-rosurg Clin N Am. 2022;33:261-73.
 
3) Alalami AA, et al. Laryngospasm:review of different prevention and treatment modalities.Paediatr Anaesth. 2008;18:281-8.
PubMed
P.17 掲載の参考文献
1) Adrion C, et al. BEMED Study Group. Efficacy and safety of betahistine treatment in patients with Meniere's disease:primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial(BEMED trial). BMJ. 2016;352:h6816.
 
2) Zhang L, et al. Fatal diphenidol poisoning:a case report and a retrospective study of 16 cases.Forensic Sci Med Pathol. 2015;11:570-6.
 
3) Simons FER. Advances in H1-antihistamines. N Engl J Med. 2004;351:2203-17.
PubMed
P.18 掲載の参考文献
1) Norman G, et al. Antiseptics for burns. Cochrane Database Syst Rev. 2017;7:CD011821.
PubMed
2) Silverberg JI.Atopic dermatitis:an evidence-based treatment update. Am J Clin Dermatol. 2014;15:149-64.
PubMed
P.19 掲載の参考文献
1) Avni T, et al. Vasopressors for the treatment of septic shock:systematic review and meta-analysis. PLoS One. 2015;10:e0129305.
PubMed
2) Brewer JM, et al. Can vasopressors safely be administered through peripheral intra-venous catheters compared with central venous catheters? Ann Emerg Med. 2015;66:629-31.
 
3) Ricard JD, et al. Central or peripheral catheters for initial venous access of ICU patients:a randomized controlled trial. Crit Care Med. 2013;41:2108-15.
 
P.21 掲載の参考文献
1) Zahed R, et al. Topical tranexamic acid compared with anterior nasal packing for treatment of epistaxis in patients taking antiplatelet drugs:randomized controlled trial. Acad Emerg Med. 2018;25:261-6.
PubMed
2) Reuben A, et al. Novel use of tranexamic acid to reduce the need for Nasal Packing in Epistaxis(NoPac)randomised controlled trial:research protocol. BMJ Open. 2019;9:e026882.
PubMed
3) Janapala RN, et al. Efficacy of topical tranexamic acid in epistaxis:a systematic review and meta-analysis. Am J Emerg Med. 2022;51:169-75.
PubMed
P.23 掲載の参考文献
1) 日本医療評価機構医療事故防止事業部. 医療事故情報収集等事業 医療安全情報. No.108 2015年11月アドレナリンの濃度間違い. In:医療事故情報収集等事業医療安全情報集 No.101～No.150(2015年4月～2019年5月). 2019.
 
1) Lau JY, et al. Omeprazole before endoscopy in patients with gastrointestinal bleed-ing. N Engl J Med. 2007;356:1631-40.
 
2) Zhang J, et al. Intravenous versus oral omeprazole on patients with high risk bleed-ing peptic ulcers:a prospective randomized clinical trial protocol. Medicine(Balti-more). 2021;100:e25136.
 
P.24 掲載の参考文献
1) Hollander-Rodriguez JC, et al. Hyperkalemia. Am Fam Physician. 2006;73:283-90.
PubMed
P.25 掲載の参考文献
1) Shi Q, et al. Comparative efficacy of pharmacological and nonpharmacological treat-ments for chronic idiopathic constipation in China:a Bayesian network meta-anal-ysis. BMC Complement Altern Med. 2019;19:311.
 
P.26 掲載の参考文献
1) Enomoto S, et al. Steakhouse syndrome causing large esophageal ulcer and steno-sis. World J Gastrointest Endosc. 2011;3:101-4.
 
1) Burton FM, et al. Propofol Target-Controlled Infusion in Emergency Department Sedation(ProTEDS):a multicentre, single-arm feasibility study. Emerg Med J. 2021;38:205-10.
PubMed
2) Afzalimoghaddam M, et al. Comparing diazepam plus fentanyl with midazolam plus fentanyl in the moderate procedural sedation of anterior shoulder dislocations:a randomized clinical trial. J Emerg Med. 2021;60:1-7.
PubMed
3) Masoumi K, et al. Dexmedetomidine versus midazolam-fentanyl in procedural anal-gesia sedation for reduction of anterior shoulder dislocation:a randomized clinical trial. Rev Recent Clin Trials. 2019;14:269-74.
 
P.28 掲載の参考文献
1) Holdgate A, et al. Nonsteroidal anti-inflammatory drugs(NSAIDs)versus opioids for acute renal colic. Cochrane Database Syst Rev. 2004;1:CD004137.
PubMed
1) Esh CJ, et al. Pharmacological hypotheses:is acetaminophen selective in its cyclo-oxygenase inhibition? Pharmacol Res Perspect. 2021;9:e00835.
 
2) KandaSwamy GV, et al. Randomized double blinded placebo controlled trial compar-ing diclofenac and piroxicam in management of acute renal colic and its clinicalimplications. Urol J. 2015;12:2069-73.
 
3) Glazier HS. Potentiation of pain relief with hydroxyzine:a therapeutic myth? DICP. 1990;24:484-8.
PubMed
P.30 掲載の参考文献
1) アメリカ心臓協会. ハイライト 2020アメリカ心臓協会(American Heart Association)CPRおよびECCのガイドライン. https://cpr.heart.org/-/media/cpr-files/cpr-guidelines-files/highlights/hghlghts_2020eccguidelines_japanese.pdf
 
P.31 掲載の参考文献
1) JRC蘇生ガイドライン2020作成編集委員会. JRC蘇生ガイドライン2020. 東京:医学書院;2021.
 
2) Soar J, et al. Adult advanced life support:2020 International Consensus on Cardio-pulmonary Resuscitation and Emergency Cardiovascular Care Science with Treat-ment Recommendations. Resuscitation. 2020;156:A80-119.
 
3) Kudenchuk PJ, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med. 1999;341:871-8.
PubMed
P.32 掲載の参考文献
1) Bruccoleri RE, et al. A literature review of the use of sodium bicarbonate for the treatment of QRS widening. J Med Toxicol. 2016;12:121-9.
PubMed
P.33 掲載の参考文献
1) Goto T, et al. Advancing emergency airway management practice and research. Acute Med Surg. 2019;6:336-51.
PubMed
2) Higgs A, et al. Guidelines for the management of tracheal intubation in critically ill adults. Br J Anaesth. 2018;120:323-52.
PubMed
P.35 掲載の参考文献
1) Patricio D, et al. Comparison of extracorporeal and conventional cardiopulmonary resuscitation:a retrospective propensity score matched study. Crit Care. 2019;23:27.
PubMed
2) Richardson ASC, et al. Extracorporeal cardiopulmonary resuscitation in adults.Interim Guideline Consensus Statement From the Extracorporeal Life Support Organization. ASAIO J. 2021;67:221-8.
PubMed
P.36 掲載の参考文献
1) Gonella S, et al. Interventions to reduce arterial puncture-related pain:a systematic review and meta-analysis. Int J Nurs Stud. 2022;126:104131.
 
2) France JE, et al. Anaesthesia for arterial puncture in the emergency department:a randomized trial of subcutaneous lidocaine, ethyl chloride or nothing. Eur J Emerg Med. 2008;15:218-20.
PubMed
3) Yildiz iU, et al. Effectiveness of lidocaine spray on radial arterial puncture pain:a randomized double-blind placebo controlled trial. Am J Emerg Med. 2021;50:724-8.
 
P.37 掲載の参考文献
1) Kusumoto FM, et al. 2018 ACC/AHA/HRS Guideline on the Evaluation and Manage-ment of Patients With Bradycardia and Cardiac Conduction Delay:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2019;140:e382-482.
 
P.39 掲載の参考文献
1) CSLベーリング. ケイセントラ静注用500/ケイセントラ静注用1000添付文書.
 
2) Steiner T, et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists(INCH):a randomised trial. Lancet Neurol. 2016;15:566-73.
 
3) Sarode R, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding:a randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128:1234-43.
PubMed
P.40 掲載の参考文献
1) 日本外傷学会, 他. 外傷初期診療ガイドラインJATEC改訂第6版. 東京:へるす出版;2021.
 
2) Maegele M, et al. Early coagulopathy in multiple injury:an analysis from the German Trauma Registry in 8724 patients. Injury. 2007;38:298-304.
PubMed
3) Spahn DR, et al. Management of bleeding and coagulopathy following major trau-ma:an updated European guideline. Critical Care. 2013:17;R76.
 
P.41 掲載の参考文献
1) 日本外傷学会, 他. 外傷初期診療ガイドラインJATEC改訂第6版. 東京:へるす出版;2021.
 
2) Schreiber MA, et al. A controlled resuscitation strategy is feasible and safe in hypo-tensive trauma patients:results of a prospective randomized pilot trial. J Trauma Acute Care Surg. 2015;78:687-95.
 
3) 頭部外傷治療・管理のガイドライン作成委員会, 編. 頭部外傷治療・管理のガイドライン. 第4版. 東京:医学書院;2019.
 
P.42 掲載の参考文献
1) Wang K, et al. Corrigendum to "Tranexamic acid-a narrative review for the emer-gency medicine clinician" [Am J Emerg Med. 2022 Mar 22;56:33-44]. Am J Emerg Med. 2022;58:353.
 
2) CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage(CRASH-2):a randomised, placebo-controlled trial. Lancet. 2010;376:23-32.
 
3) CRASH-2 collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients:an exploratory analysis of the CRASH-2 randomised con-trolled trial. Lancet. 2011;377:1096-101, 1101. e1-2.
 
P.44 掲載の参考文献
1) Zehtabchi S. Evidence-based emergency medicine/critically appraised topic. The role of antibiotic prophylaxis for prevention of infection in patients with simple hand lacerations.Ann Emerg Med. 2007;49:682-9.e1.
 
2) Stevens DL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections:2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10-52.
 
P.45 掲載の参考文献
1) モルヒネ塩酸塩添付文書.
 
2) 第一三共株式会社. フェンタニルクエン酸塩添付文書.
 
P.46 掲載の参考文献
1) Roberts JR, et al. Roberts and Hedge's Clinical Procedures in Emergency Medicine and Acute Care. Elsevier;2018.
 
2) Epstein Y, et al. Heatstroke. N Engl J Med. 2019;380:2449-59.
PubMed
3) Delaney KA, et al. Rewarming rates in urban patients with hypothermia:prediction of underlying infection. Acad Emerg Med. 2006;13:913-21.
PubMed
4) Kushimoto S, et al. The impact of body temperature abnormalities on the disease severity and outcome in patients with severe sepsis:an analysis from a multi-center, prospective survey of severe sepsis. Crit Care. 2013;17:R271.
 
P.47 掲載の参考文献
1) Glatstein M, et al. Octreotide for the treatment of sulfonylurea poisoning. Clin Toxi-col(Phila). 2012;50:795-804.
 
1) 国立研究開発法人量子科学技術研究開発機構 医療被ばく研究情報ネットワーク(J-RIME). 小児画像診断における放射線被ばくリスクの伝え方 医療に関する便益とリスクの議論をサポートする情報. 2017. p.12-29.
 
2) 相田典子. こどもに優しい画像診断を目指して. 日小児放線会誌. 2022;38:21-8.
Medical*Online
3) 日本小児救急医学会. エビデンスに基づいた子どもの腹部救急診療ガイドライン2017. 2017.
 
P.48 掲載の参考文献
1) Shaker M, et al. Simulation of health and economic benefits of extended observation of resolved anaphylaxis. JAMA Netw Open. 2019;2:e1913951.
PubMed
P.50 掲載の参考文献
1) Kerber KA, et al. Stroke among patients with dizziness, vertigo, and imbalance in the emergency department:a population-based study. Stroke 2006;37:2484-7.
PubMed
2) Choi JH, et al. Isolated vestibular syndrome in posterior circulation stroke:frequency and involved structures. Neurol Clin Pract. 2014;4:410-8.
PubMed
3) Kattah JC, et al. HINTS to diagnose stroke in the acute vestibular syndrome:three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke. 2009;40:3504-10.
PubMed
4) Saber Tehrani AS, et al. Small strokes causing severe vertigo:frequency of false-negative MRIs and non-lacunar mechanisms. Neurology. 2014;83:169-73.
 
5) 坂本 壮, 編著. めまい診療 根拠をもって対応できる! レジデントノート. 2022;24:1098-1101.
 
6) Ohle R, et al. Can emergency physicians accurately rule out a central cause of ver-tigo using the HINTS examination? A systematic review and meta-analysis. Acad Emerg Med. 2020;27:887-96.
 
P.52 掲載の参考文献
1) Stiell IG, et al. The Canadian CT Head Rule for patients with minor head injury. Lan-cet. 2001;357:1391-6.
 
2) Fournier N, et al. Adapting the Canadian CT head rule age criteria for mild traumatic brain injury. Emerg Med J. 2019;36:617-9.
PubMed
3) Davey K, et al. Application of the Canadian Computed Tomography Head Rule to patients with minimal head injury. Ann Emerg Med. 2018;72:342-50.
PubMed
4) 外傷初期診療ガイドラインJATEC改訂第6版. 東京:へるす出版;2021.
 
P.53 掲載の参考文献
1) Haq MFU, et al. The conundrum of contrast-induced acute kidney injury. J Thorac Dis. 2020;12:1721-7.
PubMed
2) 日本腎臓学会, 他. 腎障害患者におけるヨード造影剤使用に関するガイドライン. 日腎会誌. 2019:61:933-1081.
 
3) ACR Manual On Contrast Media 2022. ACR Committee on Drugs and Contrast Media. https://www.acr.org/-/media/acr/files/clinical-resources/contrast_media.pdf
 
4) Kooiman J, et al. Meta-analysis:serum creatinine changes following contrast enhanced CT imaging. Eur J Radiol. 2012;81:2554-61.
PubMed
5) Aycock RD, et al. Acute kidney injury after computed tomography:a meta-analysis. Ann Emerg Med. 2018;71:44-53. e4.
 
P.55 掲載の参考文献
1) Hagan PG, et al. The International Registry of Acute Aortic Dissection(IRAD):new insights into an old disease. JAMA. 2000;283:897-903.
PubMed
2) Mehta RH, et al. Acute type A aortic dissection in the elderly:clinical characteristics, management, and outcomes in the current era. J Am Coll Cardiol. 2002;40:685-92.
PubMed
3) Zitek T, et al. A retrospective analysis of serum D-dimer levels for the exclusion of acute aortic dissection. Open Access Emerg Med. 2022;14:367-73.
 
4) Rogers AM, et al. Sensitivity of the aortic dissection detection risk score, a novel guideline-based tool for identification of acute aortic dissection at initial presenta-tion:results from the international registry of acute aortic dissection. Circulation. 2011;123:2213-8.
 
5) Nazerian P, et al. Diagnostic accuracy of the aortic dissection detection risk score plus D-dimer for acute aortic syndromes:the ADvISED prospective multicenter study. Circulation. 2018;137:250-8.
PubMed
6) Bima P, et al. Systematic review of aortic dissection detection risk score plus D-dimer for diagnostic rule-out of suspected acute aortic syndromes. Acad Emerg Med. 2020;27:1013-27.
PubMed
P.57 掲載の参考文献
1) Wells PS, et al. Derivation of a simple clinical model to categorize patients probabil-ity of pulmonary embolism:increasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000;83:416-20.
 
2) Le Gal G, et al. Prediction of pulmonary embolism in the emergency department:the revised Geneva score. Ann Intern Med. 2006;144:165-71.
PubMed
3) Kline JA, et al. Clinical criteria to prevent unnecessary diagnostic testing in emer-gency department patients with suspected pulmonary embolism. J Thromb Hae-most. 2004;2:1247-55.
 
4) Konstantinides SV, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35:3033-69, 3069a-k.
 
P.58 掲載の参考文献
1) Perry JJ, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage:prospective cohort study. BMJ. 2011;343:d4277.
PubMed
2) Schwedt TJ. Thunderclap headache. Continuum(Minneap Minn). 2015;21(4 Head-ache):1058-71.
 
3) Mortimer AM, et al. Thunderclap headache:diagnostic considerations and neuroim-aging features. Clin Radiol. 2013;68:e101-13.
 
P.60 掲載の参考文献
1) Yasui T, et al. Prevalence and epidemiological characteristics of urolithiasis in Japan:national trends between 1965 and 2005. Urology. 2008;71:209-13.
PubMed
2) Eskelinen M, et al. Usefulness of history-taking, physical examination and diagnos-tic scoring in acute renal colic. Eur Urol. 1998;34:467-73.
 
3) Kartal M, et al. Prospective validation of a current algorithm including bedside US performed by emergency physicians for patients with acute flank pain suspected for renal colic. Emerg Med J. 2006;23:341-4.
PubMed
4) Luchs JS, et al. Utility of hematuria testing in patients with suspected renal colic:correlation with unenhanced helical CT results. Urology. 2002;59:839-42.
PubMed
5) Minotti B, et al. Prevalence of microhematuria in renal colic and urolithiasis:a sys-tematic review and meta-analysis. BMC Urol. 2020;20:119.
 
6) 坂本 壮. それって本当に尿管結石?! 見逃せない救急・見逃さない救急. プライマリ・ケア. 2021;6:18-24.
 
P.61 掲載の参考文献
1) Azhar B, et al. Misdiagnosis of ruptured abdominal aortic aneurysm:systematic review and meta-analysis. J Endovasc Ther. 2014;21:568-75.
PubMed
2) Trinchieri A. Epidemiological trends in urolithiasis:impact on our health care sys-tems. Urol Res. 2006;34:151-6.
 
3) Fukuhara H, et al. Internal validation of a scoring system to evaluate the probability of ureteral stones:The CHOKAI score. Am J Emerg Med. 2017;35:1859-66.
PubMed
4) Fukuhara H, et al. External validation of the CHOKAI score for the prediction of ure-teral stones:a multicenter prospective observational study. Am J Emerg Med. 2020;38:920-4.
 
P.63 掲載の参考文献
1) Hoorn EJ. Intravenous fluids:balancing solutions. J Nephrol. 2017;30:485-92.
PubMed
2) Sen A, et al. Chloride content of fluids used for large-volume resuscitation is asso-ciated with reduced survival. Crit Care Med. 2017;45:e146-53.
 
3) Gupta AA, et al. Dispelling myths and misconceptions about the treatment of acute hyperkalemia. Am J Emerg Med. 2022;52:85-91.
PubMed
P.64 掲載の参考文献
1) Walters BC, et al. Guidelines for the management of acute cervical spine and spinalcord injuries:2013 update. Neurosurgery. 2013;60(CN suppl 1):82-91.
 
1) Devlin JW, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.Crit Care Med. 2018;46:e825-73.
PubMed
2) Noel C, et al. Sedation and analgesia for mechanically ventilated patients in the emergency department. Emerg Med Clin North Am. 2019;37:545-56.
PubMed
2) Huang H, et al. Clinical Neurorestorative Therapeutic Guidelines for Spinal Cord Injury(IANR/CANR version 2019). J Orthop Translat. 2019;20:14-24.
PubMed
3) Ropper AE, et al. Acute spinal cord compression. N Engl J Med. 2017;376:1358-69.
PubMed
P.66 掲載の参考文献
1) Section 2:AKI Definition. Kidney Int Suppl(2011). 2012;2:19-36.
 
2) Gaudry S, et al. Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury(AKIKI 2):a multicentre, open-label, ran-domised, controlled trial. Lancet. 2021;397:1293-300.
 
P.67 掲載の参考文献
1) Goto T, et al. Advancing emergency airway management practice and research. Acute Med Surg. 2019;6:336-51.
PubMed
2) Higgs A, et al. Guidelines for the management of tracheal intubation in critically ill adults. Br J Anaesth. 2018;120:323-52.
PubMed
3) De Jong A, et al. Early identification of patients at risk for difficult intubation in the intensive care unit:development and validation of the MACOCHA score in a multi-center cohort study. Am J Respir Crit Care Med. 2013;187:832-9.
 
P.68 掲載の参考文献
1) Evans L, et al. Surviving Sepsis Campaign:International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49:e1063-143.
PubMed
2) 日本集中治療医学会. 日本版敗血症診療ガイドライン2020. http://www.jsicm.org/pdf/jjsicm28Suppl.pdf
 
3) Jones BE, et al. Empirical anti-MRSA vs standard antibiotic therapy and risk of 30-day mortality in patients hospitalized for pneumonia. JAMA Intern Med. 2020;180:552-60.
PubMed
P.69 掲載の参考文献
1) Young P, et al. Acetaminophen for fever in critically Ill patients with suspected infec-tion. N Engl J Med. 2015;373:2215-24.
 
2) 日本集中治療医学会. 日本版敗血症診療ガイドライン2020. http://www.jsicm.org/pdf/jjsicm28Suppl.pdf
 
3) Cantais A, et al. Acetaminophen-induced changes in systemic blood pressure in critically ill patients:results of a multicenter cohort study. Crit Care Med. 2016;44:2192-8.
PubMed
4) Schortgen F, et al. Fever control using external cooling in septic shock:a randomized controlled trial. Am J Respir Crit Care Med. 2012;185:1088-95.
PubMed
P.70 掲載の参考文献
1) 日本神経学会, 他. 細菌性髄膜炎診療ガイドライン2014. 東京:南江堂;2015.
 
2) McGill F, et al. Acute bacterial meningitis in adults. Lancet. 2016;388:3036-47.
PubMed
3) Brouwer MC, et al. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23:467-92.
PubMed
P.73 掲載の参考文献
1) da Silva JSV, et al. ASPEN consensus recommendations for refeeding syndrome. Nutr Clin Pract. 2020;35:178-95.
PubMed
2) London:National Institute for Health and Care Excellence(NICE). Nutrition support for adults:oral nutrition support, enteral tube feeding and parenteral nutrition. NICE Clinical Guidelines. No.32. 2017
 
P.74 掲載の参考文献
1) Reddel HK, et al. Global Initiative for Asthma Strategy 2021:Executive Summary and Rationale for Key Changes. Am J Respir Crit Care Med. 2022;205:17-35.
 
2) Hardy J, et al. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma(PRACTICAL):a 52-week, open-label, multicentre, superiority, randomised controlled trial. Lancet. 2019;394:919-28.
PubMed
3) Beasley R, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med. 2019;380:2020-30.
PubMed

CHAPTER 2 救急 ( 中毒 )

P.76 掲載の参考文献
1) Collins J. Awareness of local anaesthetic toxicity issues among hospital staff. Anaesthesia. 2010;65:960-1.
PubMed
2) Barrington MJ, et al. Ultrasound guidance reduces the risk of local anesthetic sys-temic toxicity following peripheral nerve blockade. Reg Anesth Pain Med. 2013;38:289-99.
 
3) Neal JM, et al. The Third American Society of Regional Anesthesia and Pain Medi-cine Practice Advisory on Local Anesthetic Systemic Toxicity:Executive Summary 2017. Reg Anesth Pain Med. 2018;43:113-23.
 
4) Hoegberg LCG, et al. Systematic review of the effect of intravenous lipid emulsion therapy for local anesthetic toxicity. Clin Toxicol(Phila). 2016;54:167-93.
PubMed
P.77 掲載の参考文献
1) Sivilotti ML, et al. Reversal of severe methanol-induced visual impairment:no evi-dence of retinal toxicity due to fomepizole. J Toxicol Clin Toxicol. 2001;39:627-31.
 
2) Pietruszko R. Human liver alcohol dehydrogenase--inhibition of methanol activity by pyrazole, 4-methylpyrazole, 4-hydroxymethylpyrazole and 4-carboxypyrazole. Bio-chem Pharmacol. 1975;24:1603-7.
 
P.78 掲載の参考文献
1) Proudfoot AT, et al. Position paper on urine alkalinization. J Toxicol Clin Toxicol. 2004;42:1-26.
PubMed
P.79 掲載の参考文献
1) Benson BE, et al. Position paper update:gastric lavage for gastrointestinal decon-tamination. Clin Toxicol(Phila). 2013;51:140-6.
 
1) Manoguerra AS, et al. Guideline on the use of ipecac syrup in the out-of-hospital management of ingested poisons. Clin Toxicol(Phila). 2005;43:1-10.
 
2) Beuhler MC, et al. The outcome of North American pediatric unintentional mush-room ingestions with various decontamination treatments:an analysis of 14 years of TESS data. Toxicon. 2009;53:437-43.
 
2) Christophersen AB, et al. Activated charcoal alone or after gastric lavage:a simu-lated large paracetamol intoxication. Br J Clin Pharmacol. 2002;53:312-7.
PubMed
P.80 掲載の参考文献
1) 野口裕司, 他. 自殺企図によるパラコート中毒3例の報告:行政介入への提言. 日救急医会関東誌. 2019;40:234-7.
 
2) 内藤裕史. パラコートジクワット. 中毒百科. 改訂第2版. 東京:南山堂;2001.
 
P.81 掲載の参考文献
1) Spivey WH, et al. A clinical trial of escalating doses of flumazenil for reversal of sus-pected benzodiazepine overdose in the emergency department. Ann Emerg Med. 1993;22:1813-21.
 
2) Sivilotti MLA. Flumazenil, naloxone and the'coma cocktail'. Br J Clin Pharmacol. 2016;81:428-36.
PubMed
P.83 掲載の参考文献
1) Goldfrank L, et al. A dosing nomogram for continuous infusion intravenous naloxone. Ann Emerg Med. 1986;15:566-70.
PubMed

CHAPTER 3 緩和救急系

P.84 掲載の参考文献
1) Bengoechea I, et al. Opioid use at the end of life and survival in a hospital at home unit. J Palliat Med. 2010;13:1079-83.
 
P.85 掲載の参考文献
1) 日本緩和医療学会, 編. がん患者の呼吸器症状の緩和に関するガイドライン(2016年版). 東京:金原出版;2016.
 
P.86 掲載の参考文献
1) 日本緩和医療学会, 編. がん患者の消化器症状の緩和に関するガイドライン(2017年版). 金原出版;2017.
 
P.87 掲載の参考文献
1) Bruera E, et al. Parenteral hydration in patients with advanced cancer:a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol. 2013;31:111-8.
 
1) 日本集中治療医学会倫理委員会. DNAR(Do Not Attempt Resuscitation)の考え方. 日集中医誌. 2017;24:210-5.
 
2) 日本緩和医療学会, 編. 終末期がん患者の輸液療法に関するガイドライン(2013年版). 東京:金原出版;2013.
 

CHAPTER 4 プライマリ・ケア救急

P.88 掲載の参考文献
1) Wilcox CL, et al. Heated debates:hot-water immersion or ice packs as first aid for Cnidarian envenomations? Toxins(Basel). 2016;8:97.
PubMed
2) Inomata N, et al. Surfing as a risk factor for sensitization to poly(γ-glutamic acid)in fermented soybeans, natto, allergy. Allergol Int. 2018;67:341-6.
 
P.90 掲載の参考文献
1) Ganz DA, et al. Prevention of falls in community-dwelling older adults. N Engl J Med. 2020;382:734-43.
PubMed
2) Ellis G, et al. Comprehensive geriatric assessment for older adults admitted to hos-pital. Cochrane Database Syst Rev. 2017;9:CD006211.
 
P.91 掲載の参考文献
1) Barsky AJ. The iatrogenic potential of the physician's words. JAMA. 2017;318:2425-6.
PubMed
2) Cocco G. Erectile dysfunction after therapy with metoprolol:the Hawthorne effect. Cardiology. 2009;112:174-7.
PubMed
3) Gupta A, et al. Adverse events associated with unblinded, but not with blinded, sta-tin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm(ASCOT-LLA):a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Lancet. 2017;389:2473-81.
 
4) クリフトン・K. ミーダー, 編. ドクターズルール425;医師の心得集. 東京:南江堂;1994.
 
P.92 掲載の参考文献
1) Barnett N. Taking a person-centred approach to managing polypharmacy. Specialist Pharmacy Service. 2022.
 
2) Ravn-Nielsen LV, et al. Effect of an in-hospital multifaceted clinical pharmacist intervention on the risk of readmission:a randomized clinical trial. JAMA Intern Med. 2018;178:375-82.
 
P.93 掲載の参考文献
1) Townsend P. The family life of old people:an inquiry in east London. Routledge and Kegan Paul;1957.
 
2) Aoki T, et al. Social isolation and patient experience in older adults. Ann Fam Med. 2018;16:393-8.
PubMed
3) Tomioka K, et al. Association between social participation and 3-year change in instrumental activities of daily living in community-dwelling elderly adults. J Am Geriatr Soc. 2017;65:107-13.
PubMed
P.94 掲載の参考文献
1) Palmer BF. Electrolyte disturbances in patients with chronic alcohol-use disorder. N Engl J Med. 2017;377:1368-77.
PubMed
2) Ono K, et al. JCS/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias. Circ J. 2022;86:1790-924.
PubMed
3) Yu ASL. Hypomagnesemia:causes of hypomagnesemia. UpToDate;2022.
 
P.95 掲載の参考文献
1) Onishi S, et al. Cathartic-induced fatal hypermagnesemia in the elderly. Intern Med. 2006;45:207-10.
PubMed
2) Yu ASL, et al. Hypermagnesemia:causes, symptoms, and treatment. UpToDate;2022.
 
P.96 掲載の参考文献
1) 日本骨粗鬆症学会, 他. 骨粗鬆症の予防と治療ガイドライン2015年版. 東京:ライフサイエンス出版;2015.
 
2) Hanada S, et al. Calcium-alkali syndrome due to vitamin D administration and mag-nesium oxide administration. Am J Kidney Dis. 2009;53:711-4.
 
3) Shane E. Clinical manifestations of hypercalcemia. UpToDate;2021.
 
4) Lindner G, et al. Hypercalcemia in the ED:prevalence, etiology, and outcome. Am J Emerg Med. 2013;31:657-60.
PubMed
P.98 掲載の参考文献
1) Fraquelli M, et al. Non-steroid anti-inflammatory drugs for biliary colic. Cochrane Database Syst Rev. 2016;9:CD006390.
PubMed
2) Akriviadis AE, et al. Treatment of biliary colic with diclofenac:a randomized, double-blind, placebo-controlled study. Gastroenterology. 1997;113:225-31.
 
3) Hapca S, et al. Biliary colic. BMJ. 2021;374:n2085.
PubMed
P.99 掲載の参考文献
1) Seppala LJ, et al. EuGMS Task and Finish group on Fall-Risk-Increasing Drugs(FRIDs):Position on knowledge dissemination, management, and future research. Drugs Aging. 2019;36:299-307.
 
2) Gray SL, et al. Interventions to reduce fall-risk-increasing drug use to prevent falls:A narrative review of randomized trials. Drugs Aging. 2021;38:301-9.
 
3) Goldberg EM, et al. Can an Emergency department-initiated intervention prevent subsequent falls and health care use in older adults? A randomized controlled trial. Ann Emerg Med. 2020 Dec;76:739-750
 
P.100 掲載の参考文献
1) Jenkins C, et al. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328:434-40.
PubMed
2) Stevenson DD, et al. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol. 2006;118:773-86.
PubMed
3) Morales DR, et al. Safety risks for patients with aspirin-exacerbated respiratory dis-ease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors:Meta-analysis of controlled clinical trials. J Allergy Clin Immunol. 2014;134:40-5.
 
P.102 掲載の参考文献
1) DuPont HL. Acute infectious diarrhea in immunocompetent adults. N Engl J Med 2014;370:1532-40.
PubMed
2) Riddle MS, et al. ACG Clinical Guideline:Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. Am J Gastroenterol. 2016 May;111:602-22.
PubMed
3) Riddle MS, et al. Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea:a systematic review and meta-analysis. Clin Infect Dis. 2008;47:1007-14.
PubMed
P.104 掲載の参考文献
1) Ely JW, et al. Approach to leg edema of unclear etiology. J Am Board Fam Med. 2006;19:148-60.
 
2) Trayes KP, et al. Edema:diagnosis and management. Am Fam Physician. 2013;88:102-10.
PubMed
3) Makani H, et al. Peripheral edema associated with calcium channel blockers:inci-dence and withdrawal rate--a meta-analysis of randomized trials. J Hypertens. 2011;29:1270-80.
 
4) Whelton A, et al. Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen. Kidney Int. 2006;70:1495-502.
PubMed
5) Ogawa S, et al. Pregabalin treatment for peripheral neuropathic pain:a review of safety data from randomized controlled trials conducted in Japan and in the west. Drug Saf. 2012;35:793-806.
PubMed
6) Mudaliar S, et al. Thiazolidinediones, peripheral edema, and type 2 diabetes:inci-dence, pathophysiology, and clinical implications. Endocr Pract. 2003;9:406-16.
 
7) Cicero CE, et al. A case of severe leg oedema in a patient with Parkinson's disease treated with pramipexole. Postgrad Med J. 2016;92:484.
 
P.105 掲載の参考文献
1) シオノギファーマ株式会社. PL配合顆粒添付文書. https://www.info.pmda.go.jp/go/pack/1180107D1131_2_05/
 
P.106 掲載の参考文献
1) Chang SH, et al. Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation. JAMA. 2017;318:1250-9.
PubMed
2) Baillargeon J, et al. Concurrent use of warfarin and antibiotics and the risk of bleed-ing in older adults. Am J Med. 2012;125:183-9.
 
3) Vitry AI, et al. Major bleeding risk associated with warfarin and comedications in the elderly population. Pharmacoepidemiol Drug Saf. 2011;20:1057-63.
PubMed
P.108 掲載の参考文献
1) 杏林製薬株式会社. ケトプロフェン添付文書. https://www.kegg.jp/medicus-bin/japic_med?japic_code=00068890
 
P.109 掲載の参考文献
1) Dai M, et al. The prevalence and functional impact of chronic edema and lymph-edema in Japan:LIM PRINT study. Lymphat Res Biol. 2019;17:195-201.
 
2) Singh H, et al. Types and origins of diagnostic errors in primary care settings. JAMA Intern Med. 2013;173:418-25.
PubMed
3) Wehling M. Morbus diureticus in the elderly:epidemic overuse of a widely applied group of drugs. J Am Med Dir Assoc. 2013;14:437-42.
PubMed
P.110 掲載の参考文献
1) Suares NC, et al. Prevalence of, and risk factors for, chronic idiopathic constipation in the community:systematic review and meta-analysis. Am J Gastroenterol. 2011;106:1582-91;quiz 1581, 1592.
 
2) Cirocchi R, et al. The tip of the iceberg of colorectal perforation from enema:a sys-tematic review and meta-analysis. Tech Coloproctol. 2020;24:1109-19.
 
3) Hayashida R, et al. Acute kidney injury with hemolysis after glycerin enema-induced rectal injury in a patient with type 2 diabetes. Intern Med. 2020;59:1659-63.
 
4) 医薬品医療機器総合機構. グリセリン浣腸の取扱い時の注意について. PMDA医療安全情報. 2012;No.34.
 
P.111 掲載の参考文献
1) Man-Son-Hing M, et al. Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med. 1999;159:677.
 
2) Hagerty T, et al. Fall risk and anticoagulation for atrial fibrillation in the elderly:A delicate balance. Cleve Clin J Med. 2017;84:35.
PubMed
3) Lampaet A, et al. Prevalence and severity of traumatic intracranial hemorrhage in older adults with low-energy falls. J Am Geriatr Soc. 2020;68:977-82.
 
P.113 掲載の参考文献
1) Ganetsky M, et al. Risk of Intracranial Hemorrhage in Ground-level Fall With Anti-platelet or Anticoagulant Agents. Acad Emerg Med. 2017;24:1258-66.
PubMed
2) Nishijima DK, et al. The Incidence of Traumatic Intracranial Hemorrhage in Head-Injured Older Adults Transported by EMS with and without Anticoagulant or Anti-platelet Use. J Neurotrauma. 2018;35:750-9.
 
3) Probst MA, et al. Prevalence of Intracranial Injury in Adult Patients With Blunt Head Trauma With and Without Anticoagulant or Antiplatelet Use. Ann Emerg Med. 2020;75:354-64.
PubMed
4) Ikeda Y, et al. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors:a randomized clinical trial. JAMA. 2014;312:2510-20.
Medical*Online
P.114 掲載の参考文献
1) 日本高血圧学会高血圧治療ガイドライン作成委員会, 編. 高血圧治療ガイドライン2019. 東京:ライフサイエンス出版;2019
 
2) Wolf SJ, et al. Clinical policy:critical issues in the evaluation and management of adult patients in the emergency department with asymptomatic elevated blood pressure. Ann Emerg Med. 2013;62:59-68.
PubMed
3) Patel KK, et al. Characteristics and outcomes of patients presenting with hyperten-sive urgency in the office setting. JAMA Intern Med. 2016;176:981-8.
 
4) Mancusi S, et al. Characteristics and outcomes of patients presenting with hyper-tensive urgency in the office setting:The campania salute network. Am J Hyper-tens. 2020;33:414-21
 
P.116 掲載の参考文献
1) Regan LA, et al. Slower infusion of metoclopramide decreases the rate of akathisia. Am J Emerg Med. 2009;27:475-80.
PubMed
2) Parlak I, et al. Intravenous administration of metoclopramide by 2 min bolus vs 15 min infusion:does it affect the improvement of headache while reducing the side effects? Postgrad Med J. 2007;83:664-8.
PubMed
3) Egerton-Warburton D, et al. Antiemetic use for nausea and vomiting in adult emer-gency department patients:Randomized controlled trial comparing ondansetron, Metoclopramide, and Placebo. Ann Emerg Med. 2014;64:526-32.
 
4) Dhakal OP, et al. Domperidone-induced dystonia:a rare and troublesome complica-tion. BMJ Case Rep. 2014;2014:bcr2013200282.
 

CHAPTER 5 循環器系

P.118 掲載の参考文献
1) Nagai R, et al. Urgent management of rapid heart rate in patients with atrial fibrilla-tion/flutter and left ventricular dysfunction. Circ J. 2013;77:908-16.
 
2) 小野薬品工業株式会社. 医療用医薬品:オノアクト. https://www.kegg.jp/medi-cus-bin/japic_med?japic_code=00065350.
 
P.119 掲載の参考文献
1) Alboni P, et al. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. N Engl J Med. 351:2384-91.
PubMed
2) Nabar A, et al. Class IC antiarrhythmic drug induced atrial flutter:electrocardio-graphic and electrophysiological findings and their importance for long term out-come after right atrial isthmus ablation. Heart. 2001;85:424-9.
 
3) 第一三共株式会社. サンリズムカプセル25mg/サンリズムカプセル50mg. https://www.info.pmda.go.jp/go/pack/2129008M1024_3_10/.
 
P.120 掲載の参考文献
1) 日本循環器学会, 他. 2020年改訂版 不整脈薬物治療ガイドライン. 2022. http://www.j-circ.or.jp/cms/wp-content/uploads/2020/01/JCS2020_Ono.pdf.
 
1) Heidenreich PA, et al. 2022AHA/ACC/HFSA Guideline for the Management of Heart Failure:A Report of the American College of Cardiology/American Heart Associa-tion Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e895-1032.
 
2) 日本循環器学会, 他.急性・慢性心不全診療ガイドライン(2017年改訂版). 2022. https://www.j-circ.or.jp/cms/wp-content/uploads/2017/06/JCS2017_tsutsui_h.pdf.
 
P.121 掲載の参考文献
1) 日本循環器学会, 他. 急性冠症候群ガイドライン(2018年改訂版). 2019. https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2018_kimura.pdf.
 
P.122 掲載の参考文献
1) O'Connor CM, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011;365:32-43.
PubMed
2) Nagai T, et al. Effect of intravenous carperitide versus nitrates as first-line vasodila-tors on in-hospital outcomes in hospitalized patients with acute heart failure:insight from a nationwide claim-based database. Int J Cardiol. 2019;280:104-9.
 
3) Mizuno A, et al. The impact of carperitide usage on the cost of hospitalization and outcome in patients with acute heart failure:high value care vs. low value care campaign in Japan. Int J Cardiol. 2017;241:243-8.
PubMed
4) Matsue Y, et al. Carperitide is associated with increased in-hospital mortality in acute heart failure:a propensity score-matched analysis. J Card Fail. 2015;21:859-64.
PubMed
5) Nogi K, et al. Effect of carperitide on the 1 year prognosis of patients with acut decompensated heart failure. ESC Heart Fail. 2022;9:1061-70.
 
P.123 掲載の参考文献
1) Hofmann R, et al. Oxygen therapy in suspected acute myocardial infarction.N Engl J Med. 2017;377:1240-49.
PubMed
1) Morcos SK, et al. The haemodynamic effects of iodinated water soluble radiographic contrast media:a review. Eur J Radiol.1998;29:31-46.
PubMed
2) 日本循環器学会, 他. 急性冠症候群ガイドライン(2018年改訂版). 2019. https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2018_kimura.pdf.
 
2) John AM, et al. Evaluation of blood pressure variations during the administration of intravascular contrast media in cect abdomen. Asian J Pharm Clin Res. 2018;11:309-11.
 
P.124 掲載の参考文献
1) Triposkiadis FK, et al. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion:the Dopamine in Acute Decompensated Heart Failure II(DAD-HF II)trial. Int J Cardiol. 2014;172:115-21.
PubMed
2) Bellomo R, et al. Low-dose dopamine in patients with early renal dysfunction:a pla-cebo-controlled randomised trial. Australian and New Zealand Intensive Care Soci-ety(ANZICS)Clinical Trials Group. Lancet. 2000;356:2139-43.
 
3) Chen HH, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction:the ROSE acute heart failure randomized trial. JAMA. 2013;310:2533-43.
 
4) De Backer D, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779-89.
 
P.125 掲載の参考文献
1) Templin C, et al. Clinical features and outcomes of Takotsubo(stress)cardiomyop-athy. N Engl J Med. 2015;373:929-38.
 
2) Ansari U, et al. Clinical outcomes associated with catecholamine use in patients diagnosed with Takotsubo cardiomyopathy. BMC Cardiovasc Disord. 2018;18:54
PubMed

CHAPTER 6 呼吸器系

P.126 掲載の参考文献
1) Short PM, et al. Effect of beta blockers in treatment of chronic obstructive pulmo-nary disease:a retrospective cohort study. BMJ. 2011;342:d2549.
PubMed
2) Nielsen AO, et al. β-blocker therapy and risk of chronic obstructive pulmonary dis-ease-A Danish nationwide study of 1・3 million individuals. EClinicalMedicine. 2019;7:21-6.
 
3) Parkin L, et al. Underuse of beta-blockers by patients with COPD and co-morbid acute coronary syndrome:a nationwide follow-up study in New Zealand. Respirol-ogy. 2020;25:173-82
 
P.128 掲載の参考文献
1) Hirst PH, et al. A comparison of the lung deposition of budesonide from Easyhaler, Turbuhaler and pMDI plus spacer in asthmatic patients. Respir Med. 2001;95:720-7.
PubMed
1) Sehgal IS, et al. Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis:an open-label, randomised controlled trial in India. Lancet Infect Dis. 2022;22:1052-61
 
P.130 掲載の参考文献
1) Faber MS, et al. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther. 2004;76:178-84.
PubMed
2) Nair P, et al. Addition of intravenous aminophylline to inhaled beta(2)-agonists in adults with acute asthma. Cochrane Database Syst Rev. 2012;12:CD002742.
PubMed
P.131 掲載の参考文献
1) Andersen H, et al. NSAID-exacerbated respiratory disease:a population study. ERJ Open Res. 2022;8:00462-2021.
PubMed
1) ファイザー株式会社. フラベリック錠20mg添付文書. https://www.info.pmda.go.jp/go/pack/2229007F1042_2_02/
 
2) Amano H, et al. Methylprednisolone-induced anaphylaxis diagnosed by intradermal skin test:a case report. Allergy Asthma Clin Immunol. 2021;17:70
PubMed
2) Hamed SA. The auditory and vestibular toxicities induced by antiepileptic drugs. Expert Opin Drug Saf. 2017;16:1281-94
 
P.132 掲載の参考文献
1) Borekci S, et al. Annual FEV1 loss in patients with noncystic fibrosis bronchiectasis and affecting factors. South Med J. 2022;115:328-32.
PubMed
2) Jayaram L, et al. Tiotropium treatment for bronchiectasis:a randomised, placebo-controlled, crossover trial. Eur Respir J. 2021;59:2102184.
 
3) Polverino E, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50:1700629.
PubMed
P.133 掲載の参考文献
1) Jeon CY, et al. Use of fluoroquinolone antibiotics leads to tuberculosis treatment delay in a South African gold mining community. Int J Tuberc Lung Dis. 2011;15:77-83.
 
2) Wang JY, et al. Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas. Thorax. 2006;61:903-8.
PubMed
3) Yoon YS, et al. Impact of fluoroquinolones on the diagnosis of pulmonary tuberculo-sis initially treated as bacterial pneumonia. Int J Tuberc Lung Dis. 2005;9:1215-9.
 
P.134 掲載の参考文献
1) Kudoh S, et al. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1829-32.
 
2) Tanabe T, et al. Clarithromycin inhibits interleukin-13-induced goblet cell hyperpla-sia in human airway cells. Am J Respir Cell Mol Biol. 2011;45:1075-83.
 
3) Griffith DE, et al. Clinical and molecular analysis of macrolide resistance in Myco-bacterium avium complex lung disease. Am J Respir Crit Care Med. 2006;174:928-34.
 
P.135 掲載の参考文献
1) Idiopathic Pulmonary Fibrosis Clinical Research Network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012;366:1968-77.
 

CHAPTER 7 感染症系

P.137 掲載の参考文献
1) 日本臨床腫瘍学会, 編. 発熱性好中球減少症(FN)診療ガイドライン 改訂第2版～がん薬物療法時の感染対策～. 東京:南江堂;2017.
 
2) Taplitz RA, et al. Outpatient management of fever and neutropenia in adults treated for malignancy:American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. J Clin Oncol. 2018;36:1443-53.
 
3) Flowers CR, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy:American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31:794-810.
 
P.138 掲載の参考文献
1) Gupta K, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women:a 2010 update by the Infec-tious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103-20.
 
2) Infectious Diseases Society of America.IDSA Guidance on the Treatment of Antimi-crobial-Resistant Gram-Negative Infections:Version 1.0 https://www.idsociety.org/practice-guideline/amr-guidance/
 
P.140 掲載の参考文献
1) Stevens DL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections:2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10-52.
 
2) Stevens DL, et al. Necrotizing soft-tissue infections. N Engl J Med. 2017;377:2253-65.
PubMed
3) Darenberg J, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome:a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003;37:333-40.
PubMed
P.141 掲載の参考文献
1) Yang CJ, et al. Jarisch-Herxheimer reaction after penicillin therapy among patients with syphilis in the era of the hiv infection epidemic:incidence and risk factors. Clin Infect Dis. 2010;51:976-9.
 
2) Tanizaki R, et al. High-dose oral amoxicillin plus probenecid is highly effective for syphilis in patients with HIV infection. Clin Infect Dis. 2015;61:177-83.
PubMed
3) Workowski KA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70:1-187.
PubMed
P.142 掲載の参考文献
1) European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-60.
 
2) Marciano S, et al. Spontaneous bacterial peritonitis in patients with cirrhosis:inci-dence, outcomes, and treatment strategies. Hepat Med. 2019;11:13-22.
 
3) Chavez-Tapia NC, et al. Antibiotic prophylaxis for cirrhotic patients with upper gas-trointestinal bleeding. Cochrane Database Syst Rev. 2010;2010:CD002907.
 
4) Fernandez J, et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology. 2006;131:1049-56.
PubMed
P.143 掲載の参考文献
1) Sivagnanam S, et al. Red man syndrome. Crit Care. 2003;7:119-20.
PubMed
2) Bruniera FR, et al. The use of vancomycin with its therapeutic and adverse effects:a review. Eur Rev Med Pharmacol Sci. 2015;19:694-700.
 
P.144 掲載の参考文献
1) Hayakawa K, et al. Epidemiology of extended-spectrum beta-lactamase(ESBL)pro-ducing Escherichia coli in Japan:characteristics of community-associated versus healthcare-associated ESBL E. coli. J Infect Chemother. 2017;23:117-9.
 
2) Harris PNA, et al. Effect of piperacillin-tazobactam vs meropenem on 30-day mor-tality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance:a randomized clinical trial. JAMA. 2018;320:984-94.
PubMed
3) Sharara SL, et al. Is piperacillin-tazobactam effective for the treatment of pyelone-phritis caused by extended-spectrum-β-lactamase-producing organisms? ClinInfect Dis. 2020;71:e331-7.
 
4) Rodriguez-Bano J, et al. Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing enterobacteriaceae. Clin Microbiol Rev. 2018;31:e00079-17.
PubMed
5) Fukuchi T, et al. Cefmetazole for bacteremia caused by ESBL-producing enterobac-teriaceae comparing with carbapenems. BMC Infect Dis. 2016;16:427.
 
P.146 掲載の参考文献
1) Grayson ML, et al. Kucers' the use of antibiotics a clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. 7th ed. CRC Press;2017.
 
P.147 掲載の参考文献
1) Stevens DL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections:2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10-52.
 
1) Cunha BA. Antibiotic essentials. 14th ed. Jaypee Brothers Medical Pub;2015.
 
2) 厚生労働省[Internet]. 薬剤耐性(AMR)対策について. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000120172.html
 
2) Moran GJ, et al. Effect of cephalexin plus trimethoprim-sulfamethoxazole vs cepha-lexin alone on clinical cure of uncomplicated cellulitis a randomized clinical trial. JAMA. 2017;317:2088-96.
 
3) Brindle R, et al. Assessment of antibiotic treatment of cellulitis and erysipelas:a systematic review and meta-analysis. JAMA Dermatol. 2019;155:1033-40
 
P.149 掲載の参考文献
1) 急性膵炎診療ガイドライン2021改訂出版委員会, 編. 急性膵炎診療ガイドライン2021(第5版). 東京:金原出版;2021.
 
2) Tenner S, et al. American College of Gastroenterology guideline:management of acute pancreatitis. Am J Gastroenterol. 2013;108:1400-15;1416.
 
3) Working Group IAP/APA Acute Pancreatitis Guidelines.IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013;13(4Suppl 2):e1-15
 
P.150 掲載の参考文献
1) Grayson ML, et al. Kucers' the use of antibiotics a clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. 7th ed. CRC Press;2017.
 
2) Leung JW, et al. The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime. J Antimicrob Chemother. 1990;25:399-406.
PubMed
3) van den Hazel SJ, et al. Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. Clin Infect Dis. 1994;19:279-86.
 
P.151 掲載の参考文献
1) Ebell MH, et al. How long does a cough last? Comparing patients' expectations with date from a systematic review of the literature. Ann Fam Med. 2013;11:5-13.
 
2) Smith SM, et al. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 20176:CD000245
 
P.153 掲載の参考文献
1) 国立感染症研究所薬剤耐性研究センター. 2020年JANISおよび関連サーベイランス報告. 2020.
 
2) Meropol SB, et al. Risks and benefits associated with antibiotic use for acute respi-ratory infections:a cohort study. Ann Fam Med. 2013;11:165-72.
 
3) Ray WA, et al. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012;366:1881-90.
PubMed
P.154 掲載の参考文献
1) 国立感染症研究所薬剤耐性研究センター. 2020年JANISおよび関連サーベイランス報告. 2020.
 
2) Yanagihara K, et al. Nationwide surveillance of bacterial respiratory pathogens con-ducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012:general view of the pathogens' antibacterial susceptibility. J Infect Chemother. 2017;23:587-97.
 
P.155 掲載の参考文献
1) Tiwari T, et al. National Immunization Program, CDC. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis:2005 CDC guidelines. MMWR Recomm Rep. 2005;54(RR-14):1-16.
 
P.156 掲載の参考文献
1) Fabre V, et al. Does this patient need blood cultures? A scoping review of indications for blood cultures in adult nonneutropenic inpatients. Clin Infect Dis. 2020;71:1339.
PubMed
P.157 掲載の参考文献
1) Cheung KS, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort:Systematic review and meta-analysis. Gastroenterology. 2020;159:81-95.
PubMed
2) Marignani M, et al. Acute infectious diarrhea. N Engl J Med. 2004;350:1576-7.
PubMed
3) Shane AL, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017;65:1963-73.
 
P.159 掲載の参考文献
1) Fiore AE, et al. Centers for Disease Control and Prevention(CDC).Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices(ACIP). MWWR Recomm Rep. 2011;60:1-24.
 
2) Uyeki TM, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America:2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institu-tional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis. 2019;68:e1-47.
 
3) McGeer A, et al. Toronto Invasive Bacterial Diseases Network.Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis. 2007;45:1568-75.
 
4) Butler CC, et al. Oseltamivir plus usual care versus usual care for influenza-like ill-ness in primary care:an open-label, pragmatic, randomised controlled trial. Lancet. 2020;395:42-52
 
P.161 掲載の参考文献
1) Butler CC, et al. Infectious Diseases Society of America.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resis-tant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18-55.
 
2) Silverman JA, et al. Inhibition of daptomycin by pulmonary surfactant:in vitro mod-eling and clinical impact. J Infect Dis. 2005;191:2149-52.
 
3) Cottagnoud P, et al. Daptomycin is highly efficacious against penicillin-resistant and penicillin-and quinolone-resistant pneumococci in experimental meningitis.Anti-microb Agents Chemother.2004;48:3928-33.
 
4) Crass RL, et al. Daptomycin for the treatment of Staphylococcus aureus infections complicated by septic pulmonary emboli. Diagn Microbiol Infect Dis. 2019;93:131-5.
PubMed
P.162 掲載の参考文献
1) CLSI M100-ED32:Appendix B. Intrinsic Resistance. httm://em100.edaptivedocs.net/dashboard.aspx
 
2) 原田荘平. 薬剤耐性腸内細菌目細菌の基礎と疫学Update. 臨床微生物. 2021;31:2021;31:229-38.
 
3) Tamma PD, et al. Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acine-tobacter baumannii, and Stenotrophomonas maltophilia Infections. Clin Infect Dis. 2022;74:2089-114.
 
P.164 掲載の参考文献
1) Shiffman ML, et al. Pathogenesis of ceftriaxone-associated biliary sludge.In vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology. 1990;99:1772-8.
PubMed
2) Bickford CL, et al. Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult:case report and review of the literature. Pharmacotherapy. 2005;25:1389-95
 

CHAPTER 8 産婦人科系

P.165 掲載の参考文献
1) US Preventive Services Task Force. Screening for asymptomatic bacteriuria in adults:US Preventive Services Task Force Recommendation Statement.JAMA. 2019;322:1188-94.
PubMed
2) 日本感染症学会, 他. JAID/JSC感染症治療ガイドライン2015-尿路感染症・男性性器感染症. 感染症誌.2016;90:1-30.
 
3) 日本産科婦人科学会, 他. CQ302. 切迫早産の診断と管理の注意点は? 産婦人科診療ガイドライン産科編 2020. 2020.
 
P.166 掲載の参考文献
1) Goldshtein I, et al. Association of BNT162b2 COVID-19 vaccination during preg-nancy with neonatal and early infant outcomes. JAMA Pediatr. 2022;176:470-7.
 
2) Halasa NB, et al. Effectiveness of maternal vaccination with mRNA COVID-19 vac-cine during pregnancy against COVID-19-associated hospitalization in infants aged <6 months-17 states, July 2021-January 2022. MMWR Morb Mortal Wkly Rep 2022;71:264-70.
 
3) Thompson MG, et al. Influenza vaccine effectiveness in preventing influenza-asso-ciated hospitalizations during pregnancy:a multi-country retrospective test nega-tive design study, 2010-2016. Clin Infect Dis. 2019;68:1444-53.
 
P.167 掲載の参考文献
1) 国立感染症研究所. 海外の妊婦への百日咳含有ワクチン接種に関する情報. IASR. 2019;40:14-5.
 
2) Vygen-Bonnet S, et al. Safety and effectiveness of acellular pertussis vaccination during pregnancy:a systematic review. BMC Infect Dis. 2020;20:136. https://doi.org/10.1186/s12879-020-4824-3
 
3) Fakhraei R, et al. Obstetric and perinatal health outcomes after pertussis vaccina-tion during pregnancy in Ontario, Canada:a retrospective cohort study. CMAJ Open. 2021;9:E349.
 
P.169 掲載の参考文献
1) Bouthry E, et al. Rubella and pregnancy:diagnosis, management and outcomes. Prenat Diagn. 2014;34:1246-53.
PubMed
2) 厚生労働省. 風しんの追加的対策について. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/kekkaku-kansenshou/rubella/index_00001.htm
 
P.170 掲載の参考文献
1) Lei J, et al. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020;383:1340-8.
PubMed
2) 日本産科婦人科学会, 他. CQ207. HPVワクチン接種の対象は? 産婦人科診療ガイドライン婦人科外来編 2020. 2020.
 
3) Arbyn M, et al. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018.5:CD009069.
PubMed
P.171 掲載の参考文献
1) 日本産科婦人科学会, 他. CQ305. 機能性月経困難症の治療は? 産婦人科診療ガイドライン婦人科外来編 2020. 2020.
 
2) Kazama M, et al. Prevalence of dysmenorrhea and its correlating lifestyle factors in Japanese female junior high school students. Tohoku J Exp Med. 2015;236:107-13.
PubMed
P.173 掲載の参考文献
1) Yefet E, et al. The safety of quinolones and fluoroquinolones in pregnancy:a meta-analysis. BJOG. 2018;125:1069-76.
PubMed
2) 日本産科婦人科学会, 他. CQ104. 添付文書上いわゆる禁忌の医薬品のうち, 妊娠初期のみに使用された場合, 臨床的に有意な胎児への影響はないと判断してよい医薬品は? 産婦人科診療ガイドライン産科編 2020. 2020.
 
P.174 掲載の参考文献
1) Casagrande D, et al. Low back pain and pelvic girdle pain in pregnancy.J Am Acad Orthop Surg. 2015;23:539-49.
PubMed
2) 東京大学医学部附属病院女性診療科・産科. アスリートのためのハンドブック. Health Management for Female Athletes Special Version. http://femaleathletes.jp/document/pdf/190308_HMFASpecialVer.pdf
 
3) 厚生労働省. ケトプロフェン(外皮用剤)の妊娠中における使用について. 2014. https://www.mhlw.go.jp/www1/kinkyu/iyaku_j/iyaku_j/anzenseijyouhou/312_1.pdf
 
P.175 掲載の参考文献
1) Kalaitzopoulos DR, et al. Management of venous thromboembolism in pregnancy. Thromb Res. 2022;211:106-13.
PubMed
2) Magee LA, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for interna-tional practice. Pregnancy Hypertens. 2022;27:148-69.
 
3) Smyth RMD, et al. Interventions for varicose veins and leg oedema in pregnancy. Cochrane Database Sys Rev. 2015;2015:CD001066
 
P.176 掲載の参考文献
1) 日本産科婦人科学会, 他. CQ104. 医薬品の授乳中使用による児への影響について尋ねられたら? 産婦人科診療ガイドライン産科編 2020.2020.
 
2) ABMプロトコル委員会. ABM臨床プロトコル第4号 乳腺炎(2014年改訂版). 2014.
 
3) 国立成育医療研究センター. 授乳中に安全に使用できると考えられる薬. https://www.ncchd.go.jp/kusuri/lactation/druglist_aiu.html
 
P.177 掲載の参考文献
1) The European Medicines Agency. PRAC recommends new measures to avoid val-proate exposure in pregnancy. 2018.
 
2) 日本産科婦人科学会, 他. CQ104. 医薬品使用による胎児への影響について尋ねられたら? 産婦人科診療ガイドライン産科編2020. 2020.
 
3) 「てんかん診療ガイドライン」作成委員会, 編. てんかん診療ガイドライン2018. 医学書院;2018
 
P.178 掲載の参考文献
1)日本循環器学会/日本産科婦人科学会合同ガイドライン. 心疾患患者の妊娠・出産の適応, 管理に関するガイドライン(2018年改訂版).
 
2) 日本産科婦人科学会, 他. CQ309. 妊娠高血圧症候群と診断されたら? 産婦人科診療ガイドライン産科編2020. 2020.
 
3) Magee LA, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for interna-tional practice. Pregnancy Hypertens. 2022;27:148-69.
 
4) https://pharma-navi.bayer.jp/sites/g/files/vrxlpx9646/files/2022-12/ACR_PNS_202212050.pdf
 
P.179 掲載の参考文献
1) 日本糖尿病学会. GLP-1受容体作動薬適応外使用に関する日本糖尿病学会の見解. 2020.
 
2) ノボノルディスクファーマ株式会社. リベルサス添付文書.
 
3) Silvestris E, et al. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018;16:22.
PubMed
P.180 掲載の参考文献
1) Rothman KJ, et al. Teratogenicity of high vitamin A intake. N Engl J Med. 1995;333:1369-73.
PubMed
2) 厚生労働省. アキュテイン(ACCUTANE)(わが国で未承認の難治性ニキビ治療薬)に関する注意喚起について.
 
P.181 掲載の参考文献
1) Relke N, et al. Tranexamic acid evidence and controversies:an illustrated review. Res Pract Thromb Haemost. 2021;5:e12546.
PubMed
2) Todd N, et al. Reviewed and supported by the SOGC's Infectious Disease Commit-tee. Contraception and VTE risk in the context of COVID-19 illness. 2021.
 
3) 日本産科婦人科学会. エストロゲン製剤を含むホルモン剤や経口避妊薬を服用されている皆様へ. 2022.
 

CHAPTER 9 小児科系

P.183 掲載の参考文献
1) Bauman BH, et al. Pediatric pain management in the emergency department. Emerg Med Clin North Am. 2005;23:393-414, ix.
PubMed
2) Karbasi SA, et al. Comparison of antipyretic effectiveness of equal doses of rectal and oral acetaminophen in children. J Pediatr(Rio J). 2010;86:228-32.
 
3) 日本小児科学会薬事委員会. 解熱鎮痛薬アセトアミノフェン静注液の過量投与に関する注意喚起. 2021年12月27日公開
 
P.184 掲載の参考文献
1) Lewis DW, et al. Children's ibuprofen suspension for the acute treatment of pediat-ric migraine. Headache. 2002;42:780-6.
 
2) Parish E. Ibuprofen as effective as morphine for fracture pain in children, study shows. BMJ. 2014;349:g6581.
PubMed
3) Poonai N, et al. Oral morphine versus ibuprofen administered at home for postoper-ative orthopedic pain in children:a randomized controlled trial. CMAJ. 2017;189:E1252-8.
 
4) Bauman BH, et al. Pediatric pain management in the emergency department. Emerg Med Clin North Am. 2005;23:393-414, ix.
PubMed
5) Tan E, et al. Comparison of acetaminophen(paracetamol)with ibuprofen for treat-ment of fever or pain in children younger than 2 years:a systematic review and meta-analysis. JAMA Netw Open. 2020;3:e2022398.
 
P.185 掲載の参考文献
1) Kim MK, et al. A randomized clinical trial of analgesia in children with acute abdom-inal pain. Acad Emerg Med. 2002;9:281-7.
 
2) Green R, et al. Early analgesia for children with acute abdominal pain. Pediatrics. 2005;116:978-83.
PubMed
3) Bauman BH, et al. Pediatric pain management in the emergency department. Emerg Med Clin North Am. 2005;23:393-414, ix.
PubMed
4) Parish E. Ibuprofen as effective as morphine for fracture pain in children, study shows. BMJ. 2014 2;349:g6581.
 
5) Robb AL, et al. Pediatric Emergency Research Canada(PERC)Appendicitis Study Group. Pain management of acute appendicitis in Canadian pediatric emergency departments. CJEM. 2017;19:417-23.
 
6) Fowler M, et al. for Pediatric Emergency Research Canada. Knowledge, attitudes and practices of Canadian pediatric emergency physicians regarding short-termopioid use:a descriptive, cross-sectional survey. CMAJ Open. 2020;8:E148-55.
 
P.187 掲載の参考文献
1) Green SM, et al. Emergency Department Ketamine Meta-Analysis Study Group. Pre-dictors of emesis and recovery agitation with emergency department ketamine sedation:an individual-patient data meta-analysis of 8,282 children. Ann EmergMed. 2009;54:171-80. e1-4.
 
2) 萩原佑亮, 他. 救急室において小児に痛みを伴う処置を行う際の鎮静・鎮痛に関する前向き観察研究. 日小児会誌. 2017;121:88-92.
 
3) Larson CP Jr. Laryngospasm--the best treatment. Anesthesiology. 1998;89:1293-4.
PubMed
P.188 掲載の参考文献
1) Water with sugar and salt. Lancet. 1978;2:300-1.
PubMed
2) 谷口英喜. 経口補水療法 Oral rehydration therapy. 日生気誌. 2015;52:151-64.
 
3) Freedman SB, et al. Effect of dilute apple juice and preferred fluids vs electrolyte maintenance solution on treatment failure among children with mild gastroenteri-tis:a randomized clinical trial. JAMA. 2016;315:1966-74.
 
4) Spandorfer PR, et al. Oral versus intravenous rehydration of moderately dehydrated children:a randomized, controlled trial. Pediatrics. 2005;115:295-301.
PubMed
5) Atherly-John YC, et al. A randomized trial of oral vs intravenous rehydration in a pediatric emergency department. Arch Pediatr Adolesc Med. 2002;156:1240-3.
 
P.190 掲載の参考文献
1) Cherry JD. Clinical practice. Croup. N Engl J Med. 2008;358:384-91.
PubMed
2) Gates A, et al. Glucocorticoids for croup in children. Cochrane Database Syst Rev. 2018;8:CD001955.
PubMed
3) Parker CM, et al. Prednisolone versus dexamethasone for croup:a randomized con-trolled trial. Pediatrics. 2019;144:e20183772.
 
4) Lee JH, et al. Efficacy of low-dose nebulized epinephrine as treatment for croup:arandomized, placebo-controlled, double-blind trial. Am J Emerg Med. 2019;37:2171-6.
 
P.191 掲載の参考文献
1) 日本小児アレルギー学会. 小児気管支喘息治療・管理ガイドライン2020. 東京:協和企画;2020.
 
2) Keeney GE, et al. Dexamethasone for acute asthma exacerbations in children:a meta-analysis. Pediatrics. 2014;133:493-9.
PubMed
3) Cronin JJ, et al. A randomized trial of single-dose oral dexamethasone versus multi-dose prednisolone for acute exacerbations of asthma in children who attend the emergency department. Ann Emerg Med. 2016;67:593-601. e3.
 
4) Farber HJ, et al. Oral corticosteroid prescribing for children with asthma in a medic-aid managed care program. Pediatrics. 2017;139:e20164146.
 
P.193 掲載の参考文献
1) 日本小児神経学会, 編. 小児けいれん重積治療ガイドライン2017. 東京:診断と治療社;2017.
 
2) 日本小児神経学会小児けいれん重積状態ガイドライン改訂ワーキンググループ. 小児けいれん重積治療ガイドライン2017追加情報について. https://www.childneuro.jp/uploads/files/about/SE2017GL/25SE_201906info.pdf
 
3) Glauser T, et al. Evidence-based guideline:treatment of convulsive status epilepti-cus in children and adults:report of the Guideline Committee of the American Epi-lepsy Society. Epilepsy Curr. 2016;16:48-61.
 
P.195 掲載の参考文献
1) Egi M, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020(J-SSCG 2020). J Intensive Care. 2021;9:53.
PubMed
2) Van den Bruel A, et al. Clinicians' gut feeling about serious infections in children:observational study. BMJ. 2012;345:e6144.
PubMed
3) 笠井正志, 監修, 伊藤健太. 小児感染症のトリセツREMAKE. 東京:金原出版;2019.
 
P.196 掲載の参考文献
1) 笠井正志, 他編. 小児感染症コンサルテーション 八人の侍が答えるスキマの疑問. 東京:南山堂;2022.
 
2) 斎藤昭彦, 編. レジデントのための小児感染症診療マニュアル. 東京:医学書院;2022.
 
3) Shulman ST, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis:2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55:1279-82.
 
P.197 掲載の参考文献
1) Ramchandar N, et al. Frequency of dosing of cephalexin for oral step-down therapy of pediatric osteoarticular infections caused by methicillin-sensitive Staphylococ-cus Aureus. Pediatr Infect Dis J. 2020;39:523-5.
 
2) Gwee A, et al. Twice-and thrice-daily cephalexin dosing for Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2020;39:519-22.
PubMed
3) 笠井正志, 監, 伊藤健太. 小児感染症のトリセツREMAKE. 東京:金原出版;2019.
 
P.198 掲載の参考文献
1) Baddour LM, et al. Animal bites(dogs, cats, and other animals):Evaluation and management. UpToDate. 2022.
 
2) 笠井正志, 監, 伊藤健太. 小児感染症のトリセツREMAKE. 東京:金原出版;2019.
 
P.200 掲載の参考文献
1) 医薬品医療機器総合機構. PMDAからの医薬品適正使用のお願い. 2012.
 
2) Kobayashi H, et al. Clinical features of carnitine deficiency secondary to pivalate-conjugated antibiotic therapy. J Pediatr. 2016;173:183-7.
PubMed
3) Ito M, et al. Carnitine-related hypoglycemia caused by 3 days of pivalate antibiotic therapy in a patient with severe muscular dystrophy:a case report. BMC Pediatr. 2017;17:73.
 
4) 日本小児科学会薬事委員会. ピボキシル基含有抗菌薬の服用に関連した低カルニチン血症に係る注意喚起について. 2019.
 
P.201 掲載の参考文献
1) Chang MY, et al. Drug-induced extrapyramidal symptoms at the pediatric emergency department. Pediatr Emerg Care. 2020;36:468-72.
PubMed
2) Takahashi Y, et al. Metoclopramide-induced tremor in an infant.Mov Disord Clin Pract. 2022;9:987-9.
 
3) Leelakanok N, et al. Domperidone and risk of ventricular arrhythmia and cardiac death:a systematic review and meta-analysis. Clin Drug Investig. 2016;36:97-107.
PubMed
4) Nino-Serna LF, et al. Antiemetics in children with acute gastroenteritis:a meta-analysis. Pediatrics. 2020;145:e20193260.
PubMed
5) 佐久医師会 教えて! ドクタープロジェクトチーム. 教えて! ドクター こどもの病気とおうちケア.
 
P.202 掲載の参考文献
1) Allen SJ, et al. Probiotics for treating acute infectious diarrhea. Cochrane Database Syst Rev. 2010;2010:CD003048.
PubMed
2) Investigating Group for Prevention of AAD in Children with Pneumonia by Clostrid-ium Butyricum and Bifidobacterium. Multicenter, randomized, controlled clinical trial on preventing antibiotic-associated diarrhea in children with pneumonia using the live Clostridium butyricum and Bifidobacterium combined Powder. Zhonghua Er Ke Za Zhi. 2012;50:732-6.
 

CHAPTER 10 整形外科系

P.203 掲載の参考文献
1) Jaafar MH, et al. Efficacy of rebamipide in organic and functional dyspepsia:a sys-tematic review and meta-analysis. Dig Dis Sci. 2018;63:1250-60.
 
2) Kavitt RT, et al. Diagnosis and treatment of peptic ulcer disease. Am J Med. 2019;132:447-56.
PubMed
3) 日本消化器病学会, 他. 消化性潰瘍診療ガイドライン2015. 第2版. 東京:南江堂;2015.
 
4) Eom C-S, et al. Use of acid-suppressive drugs and risk of fracture:a meta-analysis of observational studies. Ann Fam Med. 2011;9:257-67.
PubMed
5) 第一三共株式会社. ロキソニン添付文書.
 
P.205 掲載の参考文献
1) 藤井達也. フローチャート整形外科診断. 東京:中外医学社;2020.
 
2) あゆみ製薬株式会社. カロナール添付文書.
 
3) Graham G, et al. The modern pharmacology of paracetamol:therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21:201-32.
PubMed
P.206 掲載の参考文献
1) Dresing K, et al. Casts, splints, and support bandages:nonoperative treatment and perioperative protection. Thieme;2014.
 
P.207 掲載の参考文献
1) Waler N, et al. Pain management strategies in orthopedic extremity trauma. Anes-thesiol Clin. 2021;59:48-57.
 
P.208 掲載の参考文献
1) 日本外傷学会外傷初期診療ガイドライン改訂第6版編集委員会. 改訂第6版. 外傷初期診療ガイドラインJATEC. 東京:へるす出版;2021.
 
P.210 掲載の参考文献
1) ファイザー株式会社. トラマール添付文書
 
2) ヴィアトリス製薬株式会社. リリカ添付文書
 
3) 第一三共株式会社. タリージェ添付文書
 
4) 丸山一男. 痛みの考えかた. 東京:南江堂;2014.
 
P.211 掲載の参考文献
1) Waler N, et al. Pain management strategies in orthopedic extremity trauma. Int Anesthesiol Clin. 2021;59:48-57.
PubMed

CHAPTER 11 脳神経系

P.213 掲載の参考文献
1) Charles A.Migraine. N Engl J Med. 2017;377:553-61.
PubMed
1) Rabinak CA, et al. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol. 2010;67:58-63.
PubMed
2) Pondal M, et al. Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic. J Neurol Neurosurg Psychiatry. 2013;84:130-5.
 
3) Yu XX, et al. Dopamine agonist withdrawal syndrome:a comprehensive review. J Neurol Sci. 2017;374:53-5.
PubMed
P.215 掲載の参考文献
1) 日本脳卒中学会脳卒中ガイドライン委員会, 編. 脳卒中治療ガイドライン2021. 東京:協和企画;2021.
 
P.216 掲載の参考文献
1) Kamei S, et al. Nationwide survey of the annual prevalence of viral and other neuro-logical infections in Japanese inpatients. Intern Med. 2000;39:894-900.
 
2) 日本神経感染症学会, 他編. 単純ヘルペス脳炎診療ガイドライン2017. 東京:南江堂;2017.
 
P.217 掲載の参考文献
1) 日本神経学会, 他. 細菌性髄膜炎診療ガイドライン2014. 東京:南江堂;2015.
 
P.219 掲載の参考文献
1) Brophy GM, et al. Guidelines for the evaluation and management of status epilepti-cus. Neurocrit Care. 2012;17:3-23.
 
2) 日本神経学会, 監修. てんかん診療ガイドライン2018. 東京:医学書院;2018
 
P.220 掲載の参考文献
1) Kapur J, et al. Rapid seizure-induced reduction of benzodiazepine and Zn2+sensi-tivity of hippocampal dentate granule cell GABAA receptors. J Neurosci. 1997;17:7532-40.
 
2) Waterhouse E, et al. Seizures in the elderly:nuances in presentation and treatment. Cleve Clin J Med. 2005;72:s26-37
 
P.222 掲載の参考文献
1) Apetauerova D, et al. Movement disorder emergencies. Neurol Clin. 2021;39:615-30.
PubMed
2) 松原知康. Neurology for Primary Care. J-COSMO. 2019:1;717.
 
P.224 掲載の参考文献
1) Renn BN, et al. A systematic review of practice guidelines and recommendations for discontinuation of cholinesterase inhibitors in dementia. Am J Geriatr Psychiatry. 2018;26:134-47.
PubMed
1) Taylor-Rowan M, et al. Anticholinergic burden(prognostic factor)for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome. Cochrane Database Syst Rev. 2021;5:CD013540.
 
2) American Geriatrics Society.Choosing wisely:ten things clinicians and patients should question. 2015. http://www.choosingwisely.org/societies/american-geriatrics-society/
 
2) Shared Care Partners for patients. https://sharedcarebc.ca/sites/default/files/8.%20ACB_scale_-_legal_size.pdf. [online].
 
P.225 掲載の参考文献
1) Chen B, et al. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav. 2017;76:24-31.
PubMed
2) Romoli M, et al. Pyridoxine supplementation for levetiracetam-related neuropsychi-atric adverse events:a systematic review. Epilepsy Behav. 2020;103(Pt A):106861.
 
P.226 掲載の参考文献
1) Jordan H, et al. Management of insomnia and anxiety in myasthenia gravis. J Neuro-psychiatry Clin Neurosci. 2019;31:386-91.
 
2) 日本神経学会. 重症筋無力症/ランバート・イートン筋無力症診療ガイドライン2022. 東京:南江堂;2022
 
P.227 掲載の参考文献
1) Patel NJ, et al. Hypocupremia secondary to excessive zinc supplementation and gastric surgery. Neurol Clin Pract. 2015;5:512-4.
PubMed
2) 本岡里英子, 他. 偏食による亜鉛過剰摂取が原因と考えられた銅欠乏性ミエロパチーの1例. 臨神経. 2016;56:690-3.
 
3) Prodan CI, et al. Copper deficiency after gastric surgery:a reason for caution.Am J Med Sci. 2009;337:256-8.
PubMed
4) Duncan A, et al. The risk of copper deficiency in patients prescribed zinc supple-ments. J Clin Pathol. 2015;68:723-5.
 
P.228 掲載の参考文献
1) 日本脳卒中学会脳卒中ガイドライン委員会, 編. 脳卒中治療ガイドライン2021. 東京:協和企画;2021.
 
2) 日本高血圧学会高血圧治療ガイドライン作成委員会, 編. 東京:高血圧治療ガイドライン2019. 東京:ライフサイエンス出版;2019
 
P.229 掲載の参考文献
1) 日本脳卒中学会脳卒中ガイドライン委員会, 編. 脳卒中治療ガイドライン2021. 東京:協和企画;2021.
 
P.230 掲載の参考文献
1) 日本循環器学会, 他. 感染性心内膜炎の予防と治療に関するガイドライン(2017年改訂版). 日本循環器学会. 2017
 
P.231 掲載の参考文献
1) Hall GC, et al. Triptans in migraine:the risks of stroke, cardiovascular disease, and death in practice. Neurology. 2004;62:563-8.
PubMed
2) Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012;11:906-17.
PubMed
P.232 掲載の参考文献
1) Levitz RE. Herpes simplex encephalitis:a review. Heart Lung. 1998;27:209-12.
PubMed
2) 日本神経感染症学会, 他編. 単純ヘルペス脳炎診療ガイドライン2017. 東京:南江堂;2017.
 
P.234 掲載の参考文献
1) 日本老年医学会日本医療研究開発機構研究費・高齢者の薬物治療の安全性に関する研究研究班, 編. 高齢者の安全な薬物療法ガイドライン2015. 東京:メジカルビュー社;2015
 
P.235 掲載の参考文献
1) Omichi C, et al. Association between discontinuation of benzodiazepine receptor agonists and post-operative delirium among inpatients with liaison intervention:a retrospective cohort study. Compr Psychiatry. 2021;104:152216.
PubMed
2) 日本老年医学会日本医療研究開発機構研究費・高齢者の薬物治療の安全性に関する研究研究班, 編. 高齢者の安全な薬物療法ガイドライン2015. 東京:メジカルビュー社;2015.
 

CHAPTER 12 精神科系

P.238 掲載の参考文献
1) Myrick H et al. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009;33:1582-8.
PubMed
P.240 掲載の参考文献
1) Lipowski ZJ. Delirium-acute confusional state. Oxford University Press;1990.
 
2) 木村 充. アルコール離脱せん妄. 精神医学. 2018;60:243-52.
 
3) 和田 健. せん妄の病態と治療. 精神医学. 2018;60:223-32.
 
4) 大生定義. せん妄. medicina. 2016;53:4.
 
5) 鶴田良介.痛み・不穏・せん妄の評価法-ガイドラインでの推奨の根拠と現場使用におけるコツ. intensivist. 2014;6:1
 
P.241 掲載の参考文献
1) Fournier JC, et al. Antidepressant drug effects and depression severity:a patient-level meta-analysis. JAMA. 2010;303:47-53.
PubMed
P.243 掲載の参考文献
1) 厚生労働科学研究・障害者対策総合研究事業「睡眠薬の適正使用及び減量・中止のための診療ガイドラインに関する研究班」および日本睡眠学会・睡眠薬使用ガイドライン作成ワーキンググループ, 編. 睡眠薬の適正な使用と休薬のための診療ガイドライン-出口を見据えた不眠医療マニュアル-. 2013.
 
P.244 掲載の参考文献
1) 北元 健, 他. ベンゾジアゼピン受容体作動薬の過量服用後に不穏を呈した1症例. 臨精薬理. 2018;21:821-3.
 
P.245 掲載の参考文献
1) Marriott S, et al. Benzodiazepine dependence. Avoidance and withdrawal. Drug safe. 1993;9:93-103.
 
2) 福岡県薬剤師会. くすりQ&A. https://www.fpa.or.jp/citizen/kusuri-qanda.html
 
3) 内山 真. その他の精神科診療の先達-睡眠障害 不眠症診療に最新の情報. 精神医学. 2021;63:832-9.
 
4) 内山 真, 他. 睡眠薬の常用量依存. ねむりマネージメント. 2017;4:86-90.
Medical*Online
P.248 掲載の参考文献
1) 久村正樹. 救急現場の精神科診療 若手医師が悩んだ症例から学ぶ58例. 京都:金芳堂;2021
 

CHAPTER 13 皮膚科系

P.249 掲載の参考文献
1) 江藤隆史, 他. 軟膏・クリーム配合変化ハンドブック. 第2版. 東京:じほう;2015.
 
P.250 掲載の参考文献
1) Diav-Citrin O, et al. Pregnancy outcome after gestational exposure to loratadine or antihistamines:a prospective controlled cohort study. J Allergy Clin Immunol. 2003;111:1239-43.
PubMed
2) Andersson NW, et al. Association between fexofenadine use during pregnancy andfetal outcomes. JAMA Pediatr. 2020;174:e201316.
 
3) Andersson NW, et al. Desloratadine use during pregnancy and risk of adverse fetaloutcomes:a nationwide cohort study. J Allergy Clin Immunol Pract. 2020;8:1598-605
 
P.251 掲載の参考文献
1) 高山かおる, 他. 接触皮膚炎診療ガイドライン2020. 日皮会誌. 2020;130:523-67.
 
P.252 掲載の参考文献
1) Long CC, et al. The finger-tip unit--a new practical measure. Clin Exp Dermatol. 1991;16:444-7.
PubMed
P.254 掲載の参考文献
1) Perez-Soler R, et al. Determinants of tumor response and survival with erlotinib inpatients with non--small-cell lung cancer. J Clin Oncol. 2004;22:3238-47.
 

CHAPTER 14 腎臓系

P.255 掲載の参考文献
1) Seymour CW, et al. Time to treatment and mortality during mandated emergencycare for sepsis. N Engl J Med. 2017;376:2235-44.
 
2) 日本語版敗血症診療ガイドライン. 日救急医会誌. 2021;32:S1-411.
 
P.256 掲載の参考文献
1) 平田純生, 他. 患者腎機能の正確な評価の理論と実践. 日腎薬誌 2016;5:3-18.
 
P.257 掲載の参考文献
1) Khajavi MR, et al. Effects of normal saline vs. lactated Ringer's during renal trans-plantation. Ren Fail. 2008;30:535-9.
 
2) Potura E, et al. An acetate-buffered balanced crystalloid versus 0.9% saline in patients with end-stage renal disease undergoing cadaveric renal transplantation:a prospective randomized controlled trial. Anesth Analg. 2015;120:123-9.
PubMed
P.258 掲載の参考文献
1) Moritz ML, et al. Maintenance intravenous fluids in acutely ill patients.N Engl J Med. 2015;373:1350-60.
PubMed
2) Okada M, et al. Comparison of the incidences of hyponatremia in adult postopera-tive critically ill patients receiving intravenous maintenance fluids with 140 mmol/L or 35 mmol/L of sodium:retrospective before/after observational study. J Anesth. 2017;31:657-63.
PubMed
P.259 掲載の参考文献
1) American Geriatrics Society Panel on the Pharmacological Management of Per-sistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57:1331-46.
 
2) 平田純生, 他. NSAIDsによる腎障害-Cox-2阻害薬およびアセトアミノフェンは腎障害を起こすか-. 日腎会誌. 2016;58:1059-63.
 
P.261 掲載の参考文献
1) Ellison DH. Diuretic therapy and resistance in congestive heart failure. Cardiology. 2001;96:132-43.
PubMed
2) 山口 真. 臨床で使用する利尿薬の基本. レジデントノート. 2021;23:1358-67.
 
P.262 掲載の参考文献
1) Kraut JA, et al. Lactic acidosis. N Engl J Med. 2014;371:2309-19.
PubMed
2) Jaber S, et al. BICAR-ICU Study Group.Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit(BICAR-ICU):a multicentre, open-label, randomised controlled, phase 3 trial. Lancet. 2018;392:31-40
 
P.263 掲載の参考文献
1) 薬剤性腎障害のガイドライン作成委員会. 薬剤性腎障害ガイドライン2016. 日腎会誌. 2016;58:477-555.
 
P.264 掲載の参考文献
1) 中村忠博, 他. 酸化マグネシウム製剤の腎機能低下患者における血清マグネシウム値への影響. 日腎臓病薬物療会誌. 2013;2:3-9.
Medical*Online
2) Van Laecke S, et al. Hypomagnesemia and the risk of death and GFR decline in chronic kidney disease. Am J Med. 2013;126:825-31
 

CHAPTER 15 膠原病系

P.266 掲載の参考文献
1) Jung C, et al. Management of adrenal insufficiency during the stress of medical ill-ness and surgery. Med J Aust. 2008;188:409-13.
 
2) Cooper MS, et al. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003;348:727-34.
PubMed
P.268 掲載の参考文献
1) Gross GE, et al. S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia. J Dtsch Dermatol Ges. 2020;18:55-78.
PubMed
2) 陶山恭博, 編著. (11)帯状疱疹後の脱力のご注意. In:jmedmook 76 あなたも名医!これって膠原病? コンサルト実況解説50選 ミミックに騙されない思考の道筋. 日本医事新報社;2021.
 
P.269 掲載の参考文献
1) Chapter 36.NSAIDs, acetaminophen, & drugs use in rheumatoid arthritis.In:Katzung & Trevor's pharmacology examination and board review. 13th ed. McGraw-Hill;2021.
 
2) Chandrasekharan NV, et al. COX-3, a cyclooxygenase-1 variant inhibited by acet-aminophen and other analgesic/antipyretic drugs:cloning, structure, and expres-sion. Proc Natl Acad Sci U S A. 2002;99:13926-31.
 
3) Kis B, et al. Acetaminophen and the cyclooxygenase-3 puzzle:sorting out facts, fic-tions, and uncertainties. J Pharmacol Exp Ther. 2005;315:1-7.
 
4) Schlesinger N, et al. Local ice therapy during bouts of acute gouty arthritis. J Rheu-matol. 2002;29:331-4.
 
P.270 掲載の参考文献
1) 陶山恭博, 編著. jmedmook 76 あなたも名医! これって膠原病? コンサルト実況解説50選 ミミックに騙されない思考の道筋. 東京:日本医事新報社;2021.
 
2) 陶山恭博, 他. Dr. 陶山 & Dr. 田巻の Rheumatologyコンサルト:[第4回]派手な皮疹+αがあったら. J-COSMO. 2019;1:593-601.
 
3) Lappin E, et al. Gram-positive toxic shock syndromes. Lancet Infect Dis. 2009;9:281-90.
PubMed
4) 岩田健太郎, 編, 感染症999の謎. メディカル・サイエンス・インターナショナル;2010.
 
P.271 掲載の参考文献
1) Nakagomi D, et al. Bucillamine-induced yellow nail in Japanese patients with rheu-matoid arthritis:two case reports and a review of 36 reported cases. Rheumatol Int. 2013;33:793-7.
 
2) Obayashi M, et al. Clinical course of bucillamine-induced nephropathy in patients with rheumatoid arthritis. Clin Exp Nephrol. 2003;7:275-8.
PubMed
P.272 掲載の参考文献
1) 陶山恭博, 他. Dr. 陶山 & Dr. 田巻の Rheumatologyコンサルト[第1回]ステロイドを内服している人がERにやってきたら? J-COSMO. 2019;1:26-35.
 
P.274 掲載の参考文献
1) Shea B, et al. Folic acid and folinic acid for reducing side effects in patients receiv-ing methotrexate for rheumatoid arthritis. J Rheumatol.2014;41:1049-60.
 
P.275 掲載の参考文献
1) DMW-Deutsche Medizinische Wochenschrift. 1935;61:250-3.
 
2) Gerhard Domagk-Facts. NobelPrize. org. Nobel Prize Outreach AB 2022. Mon. 30 May 2022. https://www.nobelprize.org/prizes/medicine/1939/domagk/facts/
 
3) Nunokawa T, et al. Prophylactic effect of sulfasalazine against pneumocystis pneu-monia in patients with rheumatoid arthritis:a nested case-control study. SeminArthritis Rheum. 2019;48:573-8.
 
P.277 掲載の参考文献
1) Roujeau JC, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333:1600-7.
 
2) Stern RS.Clinical practice. Exanthematous drug eruptions. N Engl J Med. 2012;366:2492-501.
PubMed

CHAPTER 16 消化器系

P.279 掲載の参考文献
1) Applegate WV. Abdominal cutaneous nerve entrapment syndrome(ACNES):a com-monly overlooked cause of abdominal pain. Perm J. 2002;6:20-7.
 
2) van Assen T, et al. Incidence of abdominal pain due to the anterior cutaneous nerve entrapment syndrome in an emergency department. Scand J Trauma Resusc EmergMed. 2015;23:19.
 
P.280 掲載の参考文献
1) 藤本和久. アニサキスアレルギー. 診断と治療. 2017;5:643-5.
Medical*Online
P.281 掲載の参考文献
1) Manabe N, et al. Characteristics of colonic diverticulitis and factors associated with complications:a Japanese multicenter, retrospective, cross-sectional study. Dis Colon Rectum. 2015;58:1174-81.
PubMed
2) Daniels L, et al. Randomized clinical trial of observational versus antibiotic treat-ment for a first episode of CT-proven uncomplicated acute diverticulitis. Br J Surg. 2017;104:52-61.
 
3) Jacobs DO. Clinical practice. Diverticulitis. N Engl J Med. 2007;357:2057-66.
PubMed
P.282 掲載の参考文献
1) Harjola PT. A rare obstruction of the coeliac artery. Report of case. Ann Chir Gynae-col Fenn. 1963;52:547-50.
 
2) 楠 裕明, 他. 第10回腹腔動脈圧迫症候群(CACS). G. I. Research. 2014;22:544-53.
 
P.283 掲載の参考文献
1) 中野弘康. 利胆薬の始め時・やめ時. In:矢吹 拓, 編. 薬の上手な出し方&やめ方. 東京:医学書院;2020.
 
P.284 掲載の参考文献
1) 急性膵炎診療ガイドライン2015改定出版委員会, 編. 急性膵炎診療ガイドライン2015. 第4版. 東京:金原出版;2015.
 
2) Wu BU, et al. Lactated Ringer's solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011;9:710-7.e1.
 
3) Crockett SD, et al. American Gastroenterological Association Institute Guideline on initial management of acute pancreatitis. Gastroenterology. 2018;154:1096-101.
PubMed
P.285 掲載の参考文献
1) Blatchford O, et al. A risk score to predict need for treatment for upper-gastrointes-tinal hemorrhage. Lancet. 2000;356:1318-21.
 
2) Ming-Chih H, et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage:a randomized trial. Hepatology. 2004;39:746-53
 
P.287 掲載の参考文献
1) 藤田芳郎. 胃腸炎は難しい. medicina. 2005;42:1020-3.
 
2) 中野弘康. 嘔気・嘔吐. In:樫山鉄矢, 他編. ER実践ハンドブック改訂版現場で活きる初期対応の手順と判断の指針. 東京:羊土社;2022.
 
P.288 掲載の参考文献
1) アルコール医学生物学研究会. JASBRAアルコール性肝障害診断基準2011年版(2021年小改訂). http://plaza.umin.ac.jp/jasbra/sub-kijyun.html
 
2) Andrici J, et al. Facial flushing response to alcohol and the risk of esophageal squa-mous cell carcinoma:a comprehensive systematic review and meta-analysis. Can-cer Epidemiol. 2016;40:31-8.
 
3) Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;252:1905-7.
PubMed
P.289 掲載の参考文献
1) Manfredini R, et al. Circadian pattern in occurrence of renal colic in an emergency department:analysis of patients' notes. BMJ. 2002;324:767.
 
2) Pathan SA, et al. A systematic review and meta-analysis comparing the efficacy of nonsteroidal anti-inflammatory drugs, opioids, and paracetamol in the treatment of acute renal colic. Eur Urol. 2018;73:583-95.
PubMed
3) Springhart W, et al. Forced versus minimal intravenous hydration in the management of acute renal colic:a randomized trial. J Endourol. 2006;20:713-6.
 
4) 武田宗和, 他. 救急外来診療における尿管結石疝痛発作に対する指圧による治療経験. 日臨救急医会誌. 2021;24:425-8.
Medical*Online

CHAPTER 17 内分泌系

P.290 掲載の参考文献
1) 日本甲状腺学会, 編. 抗甲状腺薬の副作用の特徴と注意点は? バセドウ病治療ガイドライン2019. 東京:南江堂;2019.
 
P.292 掲載の参考文献
1) 田井宣之, 他. 高カルシウム血症性クリーゼ. In:横手幸太郎, 監修. ここが知りたい!内分泌疾患診療ハンドブックver.2. 東京:中外医学社;2018.
 
P.294 掲載の参考文献
1) Imagawa A, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM StudyGroup. N Engl J Med. 2000;342:301-7.
 
2) 日本糖尿病学会. 1型糖尿病調査研究委員会報告-劇症1型糖尿病の新しい診断基準(2012). 糖尿病. 2012;55:815-20.
 
3) 日本糖尿病学会, 他. 免疫チェックポイント阻害薬による1型糖尿病. 2018. http://www.fa.kyorin.co.jp/jds/uploads/imp_201811_type1-dm.pdf
 
4) 馬殿 恵, 他. 抗PD-1抗体投与後に発症する1型糖尿病の特徴および臨床経過に関する調査報告. 糖尿病. 2019;62:37-46.
 
P.295 掲載の参考文献
1) Kitabchi AE, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32:1335-43.
PubMed
2) 日本糖尿病学会. SGLT2阻害薬の適正使用に関するRecommendation. 2022. http://www.jds.or.jp/modules/important/index.php?content_id=48
 
P.297 掲載の参考文献
1) Kitabchi AE, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32:1335-43.
PubMed

CHAPTER 18 血液内科系

P.298 掲載の参考文献
1) Cappellini MD, et al. Iron deficiency across chronic inflammatory conditions:inter-national expert opinion on definition, diagnosis, and management. Am J Hematol. 2017;92:1068-78.
 
2) Hori M, et al. Minireview:fibroblast growth factor 23 in phosphate homeostasis and bone metabolism. Endocrinology. 2011;152:4-10.
PubMed
3) Schouten BJ, et al. FGF23 elevation and hypophosphatemia after intravenous iron polymaltose:a prospective study. J Clin Endocrinol Metab. 2009;94:2332-7.
PubMed
P.299 掲載の参考文献
1) Hershko C, et al. Role of autoimmune gastritis, Helicobacter pylori and celiac dis-ease in refractory or unexplained iron deficiency anemia. Haematologica. 2005;90:585-95.
PubMed
2) Imai R, et al. Iron deficiency anemia due to the long-term use of a proton pump inhibitor. Intern Med. 2018;57:899-901.
 
3) Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372:1832-43
 
P.300 掲載の参考文献
1) Bakchoul T, et al. Drug-associated thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2018;2018:576-83.
PubMed
2) Aster RH, et al. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357:580-7.
PubMed
3) Vayne C, et al. Pathophysiology and diagnosis of drug-induced immune thrombocy-topenia. J Clin Med. 2020;9:2212.
 
P.301 掲載の参考文献
1) Dvanajscak Z, et al. Hemolysis-associated hemoglobin cast nephropathy results from a range of clinicopathologic disorders. Kidney Int. 2019;96:1400-7.
PubMed
2) Hughes M, et al. Primary bladder lymphoma:management and outcome of 12 patients with a review of the literature. Leuk Lymphoma. 2005;46:873-7.
PubMed
P.302 掲載の参考文献
1) 赤木祐貴, 他. 非ステロイド性抗炎症薬の抗血小板作用に関するPK/PD解析. 医療薬. 2015;41:404-14.
Medical*Online
2) Shibata K, et al. Influence of nonsteroidal anti-inflammatory drugs on aspirin's anti-platelet effects and suggestion of the most suitable time for administration of both agents without resulting in interaction. J Pharm Health Care Sci. 2017;3:9.
PubMed
3) Catella-Lawson F, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med. 2001;345:1809-17.
PubMed
4) Wang CL, et al. Effectiveness and safety of non-vitamin-K antagonist oral anticoag-ulants versus warfarin in atrial fibrillation patients with thrombocytopenia. J Thromb Thrombolysis. 2019;47:512-9.
 
5) Janion-Sadowska A, et al. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and thrombocytopenia. J Cardiovasc Pharmacol. 2018;72:153-60.
PubMed
6) Chalayer E, et al. Antithrombotic therapy and platelet transfusions in hematologic malignancy patients presenting chemotherapy-induced thrombocytopenia:a French survey. Transfusion. 2017;57:1717-23.
PubMed
P.304 掲載の参考文献
1) Nathan SS, et al. Survival in patients operated on for pathologic fracture:implica-tions for end-of-life orthopedic care. J Clin Oncol. 2005;23:6072-82.
 
2) Tsuda Y, et al. Complications and postoperative mortality rate after surgery for pathological femur fracture related to bone metastasis:analysis of a nationwide database. Ann Surg Oncol. 2016;23:801-10.
PubMed
3) Alvi HM, et al. Prophylactic stabilization for bone metastases, myeloma, or lym-phoma:do we need to protect the entire bone? Clin Orthop Relat Res. 2013;471:706-14.
PubMed
4) Terpos E, et al. International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. J Clin Oncol. 2013;31:2347-57
 
P.305 掲載の参考文献
1) Charshafian S , et al. Rapid fire:infectious disease emergencies in patients with cancer. Emerg Med Clin North Am. 2018;36:493-516.
PubMed
2) Taplitz RA, et al. Outpatient management of fever and neutropenia in adults treated for malignancy:American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol. 2018;36:1443-53.
 
3) Matsumura Y.Risk analysis of eculizumab-related meningococcal disease in japan using the Japanese adverse drug event report database. Drug Healthc Patient Saf. 2020;12:207-15.
PubMed
4) McNamara LA, et al. High risk for invasive meningococcal disease among patients receiving eculizumab(soliris)despite receipt of meningococcal vaccine. MMWR Morb Mortal Wkly Rep. 2017;66:734-7.
PubMed
P.306 掲載の参考文献
1) Stewart AF.Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005;352:373-9.
PubMed
2) Thomas AS, et al. Gastrointestinal lymphoma:the new mimic. BMJ Open Gastroen-terol. 2019;6:e000320.
 

CHAPTER 19 耳鼻科系

P.307 掲載の参考文献
1) 日本顔面神経研究会. 顔面神経麻痺診療の手引-Bell麻痺とHunt症候群-2011年版. 東京:金原出版;2011.
 
2) Shi J, et al. Efficacy and safety of pharmacological and physical therapies for Bell's palsy:a Bayesian Network Meta-Analysis. Front Neurol. 2022;13:868121.
PubMed
3) 日本耳鼻咽喉科頭頸部外科学会. 突発性難聴, 顔面神経麻痺等のステロイド治療におけるB型肝炎ウイルス再活性化防止に関する指針(第1版)(2020年12月10日掲載). http://www.jibika.or.jp/members/information/info_nanchou.html
 
P.309 掲載の参考文献
1) Antonelli PJ, et al. Insecticidal activity of common reagents for insect foreign bodies of the ear. Laryngoscope. 2001;111:15-20.
PubMed
P.310 掲載の参考文献
1) 日本耳科学会, 他, 編. 小児急性中耳炎診療ガイドライン2018年版. 東京:金原出版;2018.
 
1) Tran QK, et al. Prophylactic antibiotics for anterior nasal packing in emergency department:a systematic review and meta-analysis of clinically-significant infec-tions. Am J Emerg Med. 2020;38:983-9.
 
2) Kocak HE, et al. Comparison of topical treatment methods used in recurrent anterior epistaxis:a randomized clinical trial. Braz J Otorhinolaryngol. 2021;87:132-6.
PubMed

CHAPTER 20 マイナーエマージェンシー

P.311 掲載の参考文献
1) Gelston CD. Common eye emergencies. Am Fam Physician. 2013;88:515-9.
PubMed
P.312 掲載の参考文献
1) Seikaly H. Epistaxis. N Engl J Med. 2021;384:944-51.
PubMed
2) Addison A, et al. Recurrent epistaxis:predicting risk of 30-day readmission, deriva-tion and validation of RHINO-ooze score. Rhinology. 2017;55:99-105
 
P.313 掲載の参考文献
1) 参天製薬株式会社. ベノキシール点眼液0.4%添付文書.
 
2) Liang JL, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States:recommendations of the Advisory Committee on Immunization Prac-tices(ACIP). MMWR Recomm Rep. 2018;67:1-44.
 
P.314 掲載の参考文献
1) Liang JL, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States:recommendations of the Advisory Committee on Immunization Prac-tices(ACIP). MMWR Recomm Rep. 2018;67:1-44.
 

書評

最近チェックした商品履歴

Loading...